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ABSTRACT
Eugene Urrutia: The Statistical Analysis of Genetic Sequencing and Rare Variant
Association Studies
(Under the direction of Michael Wu)
Understanding the role of genetic variability in complex traits is a central goal of modern
human genetics research. So far, genome wide association tests have not been able to discover
SNPs that explain a large proportion of the heritability of disease. It is hoped that with
the advent of accessible DNA sequencing data, investigators can uncover more of the so-
called missing heritability. The added information contained in sequencing data includes rare
variants, that is, minor alleles whose population frequency is low.
We examine several existing region based rare variant association tests including burden
based tests and similarity based tests and show that each is most powerful under a certain
set of conditions which is unknown to the investigator. While some have proposed tests that
combine the features of several existing tests, none as yet has provided a test to combine
the features of all existing tests. Here, we propose one such test under the framework of the
SKAT test, and show that it is nearly as powerful as the most appropriately chosen test under
a range of scenarios.
Existing methods do not allow for missing values in the covariates. Standard use of
complete case analysis may yield misleading results, including false positives and biased
parameter estimates. To address this problem, we extend an existing maximum likelihood
strategy for accommodating partially missing covariates to the SKAT framework for rare
variant association testing. This results in a test with high power to identify genetic regions
associated with quantitative traits while still providing unbiased estimation and correct
control of type I error when covariates are missing at random. Since the framework is generic,
we also consider the application of this approach to epigenetic data.
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A wide range of variable selection approaches can be applied to isolate individual rare
variants within a region, yet there has been little evaluation of these approaches. We examine
key methods for prioritizing individual variants and examine how these procedures perform
with respect to false positives and power via application to simulated data and real data.
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Chapter 1
Introduction and Overview
In modern human genetics, it is desired to know whether genetics play a role in phenotype,
for example the presence or absence of a disease. So far, genome wide association tests
have not been able to discover SNPs that explain a large proportion of the heritability of
disease. It is hoped that with the advent of accessible DNA sequencing data, investigators
can uncover more of the so-called missing heritability. The added information contained in
sequencing data includes rare variants, that is, minor alleles whose population frequency is
low. This is in contrast to microarray technology which typically includes common single
nucleotide polymorphisms whose minor allele frequency (MAF) are relatively high. Rare
variants associated with disease have already been reported.
Statistical considerations need to be made to adjust to rare variant association testing.
Power decreases substantially when applying common variant methodology to rare variants.
The signal is lower due to fewer minor alleles present in a given study. Also, multiple
comparison corrections are a concern since the number of variants is increased dramatically.
To address these concerns, investigators have adapted a region based approach to rare
variant association testing. In this approach, all variants of a region, such as a single genomic
exome, are tested as a group. Collapsing the data and testing only the cumulative effect,
this addresses the low signal concern by amplifying over several variants and the multiple
comparison correction concern by substantially decreasing the number of tests performed. In
paper 1, we examine several existing methods including burden based tests and similarity
based tests and show that each is most powerful under a certain set of conditions which is
unknown to the investigator. While some have proposed tests that combine the features of
several existing tests, none as yet has provided a test to combine the features of all existing
tests. Here, we propose one such test under the framework of the SKAT test, and show that
it is nearly as powerful as the most appropriately chosen test under a range of scenarios.
It is of prime importance for investigators to consider important covariate information
when performing genetic sequencing studies. If individual characteristics such as demographics,
age, gender, or lifestyle, is ignored, many false positive results may be discovered which will not
hold up under subsequent study. Fortunately, most of the widely used statistical procedures
for rare variants are able to accommodate covariates. Methods have been developed to account
for missing genotype via imputation or allele dosages. However, existing methods do not
allow for missing covariates. In the case of missing covariates, misleading results may be
obtained if proper adjustments are not provided. For example, if the data are missing at
random, and only complete observations are used in the analysis, then there is a great danger
of biased parameter estimation. In paper 2, we examine the properties of complete case,
single/multiple imputation, and maximum likelihood when covariates are MCAR and MAR.
We use an existing maximum likelihood strategy via iteratively reweighted least squares and
apply it to the SKAT framework for rare variant association testing. This results in a test
that maximizes power while still providing unbiased estimation and correct control of type I
error under the condition of missing covariates under MAR.
Finally, once a region of interest has been identified, subsequent analysis is required to
prioritize and select the individual variants that drive the association. By restricting analysis
to a single region, the problem of finding individual associated variants becomes much less
high-dimensional and much more tractable. While most rare variant tests can only identify
regions associated with complex traits, variable selection procedures are well adapted to the
identification of specific variants that are responsible for the regional association. We discuss
several methods of variable selection, including univariable linear regression, multivariable
linear regression with backward/forward selection, penalized linear regression, and stability
selection. In paper 3, we examine key methods for prioritizing individual variants and examine
how these procedures perform with respect to false positives and power via application to
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simulated data and real data. Furthermore, we consider the direct use of forward selection
in conjunction with SKAT and show that this method is highly competitive and can often
select truly causal variants.
In the review of the current literature, we describe the following:
1. Statistical methods of testing whole genetic sequencing regions
2. Statistical methods for working with missing covariates
3. Statistical methods of selecting rare genetic variants within a specific genetic region
We follow with our own contributions to rare variant association testing:
1. Multiple kernel SKAT unified framework for rare variant association testing
2. Maximum likelihood based procedure for rare variant sequencing data with missing
covariates
3. Evaluation of variable selection methods for selection of individual rare variants in
sequencing studies
3
Chapter 2
Literature Review
2.1 Statistical methods of testing whole genetic sequencing regions
2.1.1 Heritability of disease
In genetic association testing, it is desired to know whether genetics play a role in
phenotype, for example the presence or absence of a disease. Heritability, the inheritance of
phenotypes such as disease resulting from genetic information alone, can be estimated using
family based studies (McNeill et al., 2004; Dwyer et al., 1999). For example, identical twins
separated at birth have identical genetic information and randomly associated environmental
factors, while random pairs of persons have random genetic similarity and randomly associated
environmental factors. Linear mixed modeling of an outcome can estimate the variance due
to heretability versus that due to environment.
Over the past two decades, genome wide association studies (GWAS) have used DNA and
RNA microarray technology to find specific genetic variants that represent the heritability
of disease. Microarrays today typically measure the DNA/RNA concentration of 100,000-
1,000,000 single nucleotide polymorphisms (SNPs), that is, common genetic variants with a
minor allele frequency of 5% or greater. However, so far, genome wide association tests have
not been able to discover SNPs explaining a large proportion of the expected heritability
of disease (Eichler et al., 2010; Kaiser, 2012). Scientists have theorized that items such as
interactions between genetic variants, prior biological information, gene pathway information,
and better use of demographics could lead to better elucidation of heritability (Manolio et al.,
2009; Zuk et al., 2012) . In this paper, we discuss another potential gain in the search for the
missing heritability: the technological advance of whole genome DNA sequencing.
The added information contained in DNA sequencing data includes rare variants, that
is, minor alleles whose population frequency is low, well below the 5% threshold of common
variants used in microarray studies. Already, rare variants associated with disease have been
reported (Cohen et al., 2006; Walsh et al., 2008; Nejentsev et al., 2009).
We begin by briefly discussing the methods previously used in GWAS and then discuss
the adaptations used in sequencing association studies.
2.1.2 Statistical methods of testing genome-wide association studies
The most popular statistical method of GWAS is regression applied to case-control or
quantitative trait data (Hunter et al., 2007; Yeager et al., 2007; Thomas et al., 2008; Scott
et al., 2007). Demographics such as gender, race, and age are controlled for and p-values
are adjusted for multiple comparisons. Chi-squared test stratified for discrete covariates can
be used but is impractical for covariates in comparison to logistic regression. For continuous
phenotypes such as blood pressure, linear regression with the identity link is used similarly
to logistic regression.
However, statistical considerations need to be made to adjust to rare variant association
testing. Power decreases substantially when applying common variant methodology to rare
variants. The signal is lower due to less minor alleles present in a given study. Also, multiple
comparison corrections are a concern since the number of variants is increased dramatically,
from the order of thousands to the order of billions. To address these concerns, investigators
have adapted a region based approach to rare variant association testing. In this approach,
all variants of a region, such as a single genomic exome, are tested as a group. Collapsing the
data and testing only the cumulative effect addresses the low signal concern by amplifying over
several variants, and the multiple comparison correction concern by substantially decreasing
the number of tests performed.
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2.1.3 Burden based sequence association tests
One class of region based methods is the burden-based class of tests. In the cohort allelic
sum test and combined multivariate collapsing test (CAST/CMC) the genetic information of
a region for an individual is collapsed to a single binary variable which takes the value 1 if
the person has at least one rare variant present in the region and 0 otherwise (Morgenthaler
and Thilly, 2007; Li and Leal, 2008). In a slight variation, the count collapsing method, the
summary variable takes the value of the total number of rare variants present in the region
of an individual (Morris and Zeggini, 2010). Additionally, one may wish to place a higher
weight on variants which are rarer, and this is done in the weighted count collapsing method
(Madsen and Browning, 2009). The burden-based rare variant association tests are similar in
that they sum over the rare variant genetic information. Thus, they are most powerful when
the effects of the variants are all in the same direction, that is, all are deleterious or all are
protective. Power is decreased when effects are in opposite directions.
Assuming continuous outcome (yi) , the above models are described below and solved
using linear regression:
CAST/CMC:
yi = αXi + βI(
p∑
j=1
zij > 0) + i
Count Collapsing:
yi = αXi + β
p∑
j=1
zij + i
Weighted Count Collapsing:
yi = αXi + β
p∑
j=1
zijwj + i
where Xi are covariates including intercept; zij is the number of rare alleles present at locus
j in individual i and takes the value 0, 1, or 2; and wj is an assigned weight, typically higher
for the rarer variables.
Additionally, several tests within the burden-based class have been proposed to address
specific concerns. Liu and Leal (2010) have proposed the kernel-based adaptive cluster
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(KBAC) to address statistical problems associated with misclassification of variant functionality,
causality, and polymorphism status, and also with gene interactions. Using the cumulative
minor-allele test (CMAT), Zawistowski et al. (2010) have broadened the scope to the application
of low-coverage sequencing and imputation data, as well as population stratification. Bhatia
(2009) proposed RARECOVER in order to take advantage of a subset within a region being
more associated with a phenotype. Still, though, none of the methods mentioned yet address
the concern of variants within a region having both deleterious and protective effects.
Investigators have developed and adapted new strategies to address this concern. Han
and Pan (2010a) introduced the data-adapted sum (aSum) test which incorporates both
marginal (univariable) analysis and common association strength to detect both protective
and deleterious effects. Ionita-Laza et al. (2011) introduced another novel strategy, the
replication-based strategy, to achieve the same. Li et al. (2010a), with their weighted haplotype
and imputation-based tests (WHaIT), added imputation capabilities to the protective/deleterious
model.
2.1.4 Similarity based sequence association tests
Others have proposed another set of tests called similarity-based methods. In this class
the question is asked whether individuals who are genetically similar are also phenotypically
similar. Neale et al. (2011) adapted the C-alpha score test to evaluate change in variance of
the allele frequency rather than change in the mean of the allele frequency in cases compared
to controls. Under the null hypothesis of no genetic association with outcome, distribution of
counts of rare alleles should follow the binomial distribution. By testing variance rather than
net effect, the test is powerful to detect genetic association when the effects of the variants
are not all in the same direction.
For each of m variants, the C-alpha test statistic contrasts the observed variance with the
expected variance of rare allele count in cases. The test assumes the binomial distribution
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and null hypothesis of equal distribution among cases and controls:
T =
1√
c
m∑
j=1
[
(zj − njp0)2 − njp0(1− p0)
]
where zj is the total rare allele count for variant j in cases only, nj is the total rare allele count
for variant j in both cases and controls, p0 is the proportion of cases out of total subjects,
and c is a standardization term.
2.1.5 Sequence Kernel Assocation Test
Another similarity-based method, the sequence kernel association test (SKAT), includes
the flexibility to custom define what is genetic similarity through a kernel function (Wu et al.,
2011). The result is an n by n matrix of pair wise genetic similarity which appears very
much like a correlation matrix. SKAT is our preferred method because it offers a general
framework that is adaptable to almost any scenario while retaining power when the kernel is
chosen appropriately. It is also flexible in that covariates can be accomodated without the
use of permutation.
SKAT is based on a semi-parametric model:
yi = xiβ + h(zi) + i
h(.) is defined by the kernel function K(., .). In general two popular kernel functions are the
dth polynomial kernel and the gaussian kernel.
Dth polynomial kernel:
K(z1, z2) = (z
T
1 z2 + ρ)
d
where d indexes the order of polynomial and ρ is an index parameter
When d = 1, this is equivalent to a linear function space with first-order basis functions:
{z1, z2, . . . , zm}. When d = 2, this is equivalent to a quadratic function space with second-
order basis functions: {zj , zjzj′}(j, j′ = 1, . . . ,m).
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Gaussian kernel:
K(z1, z2) = exp{−||z1 − z2||2/ρ}
where ρ is the scale parameter.
The Gaussian kernel is equivalent to the radial basis functions.
The kernel for the default SKAT test uses weights equal to the β(1,25) distribution
evaluated at the study-wide frequency of the particular minor allele. This produces greater
power when the rarest alleles have the most effect on the outcome:
Default SKAT kernel:
K = ZW (ZW )T
where Z is the full genetic design matrix and W is a diagonal matrix of weights
Expanded, the default SKAT kernel takes the form:
KSKAT =

w1z11 w2z12 . . . wmz1m
w1z21 w2z22 . . . wmz2m
...
...
...
...
w1zn1 w2zn2 . . . wmznm


w1z11 w2z12 . . . wmz1m
w1z21 w2z22 . . . wmz2m
...
...
...
...
w1zn1 w2zn2 . . . wmznm

T
Thus, K(z1, z2) =
∑m
j=1w
2
j z1jz2j . It is clear that K(z1, z2) approaches 1 when there is high
genetic similarity, approaches -1 when there is great genetic dissimilarity, and is close to 0
otherwise. This similarity is weighted toward rare variants.
There are several ways to estimate the parameters β and h. LSKM estimates by minimizing
a scaled penalized likelihood function.
LSKM minimizes:
J(h, β) = −1
2
n∑
i=1
{yi − xTi β − h(zi)}2 −
1
2
λ||h||2
where λ is a tuning parameter which determines the flexibility of the model. When λ=0, the
model interpolates the data, while when λ =∞, the model fits the linear model without h(z).
By the representer theorem, h(z) can be represented by
∑n
i=1 αiK(·, zi) so that the likelihood
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function can be written:
J(α, β) = −1
2
n∑
i=1
{yi − xTi β −
n∑
j=1
αiK(zi, zj)}2 − 1
2
λαTKα
with solutions
βˆ = {XT (I + λ−1K)−1X}−1XT (I + λ−1K)−1y
αˆ = λ−1(I + λ−1K)(y −Xβˆ)
However, Liu et al. (2007a) argue that the usefulness of the LSKM is limited due to the high
computing cost of estimating λ and lack of literature on estimating ρ and σ2. Thus, it is
preferable to use the linear mixed model.
Linear mixed model:
y = xβ + h+ 
where h are random effects with distribution N(0, τK) and  are residuals with distribution
N(0, σ2I). It is clear that this model is equivalent to LSKM because β and h can be derived
equivalent to those from LSKM using a standard linear mixed model estimating procedure:
 XTR−1X XTR−1
R−1X R−1 + (τK)−1

 β
h
 =
 XTR−1y
R−1y

where R = σ2I and τ = λ−1σ2
When we apply the kernel machine to genetic sequencing data, we are primarily interested
in whether or not the entire genetic region has an effect on the outcome. This test is:
H0 : h(z) = 0 vs. Ha : h(z) 6= 0. Using the linear model framework, we can equivalently test
H0 : τ = 0 vs. Ha : τ > 0. The test falls on the boundary. Also, because K is not block
diagonal, τ is not distributed as a mixture of χ20 and χ
2
1.
Liu et al. (2007a) propose testing the hypothesis by score test using REML of linear mixed
model at fixed ρ:
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SKAT score test statistic:
Qτ (βˆ, σ
2, ρ)− tr{P0K(ρ)}
where
Qτ (βˆ, σ
2, ρ) =
(y − xβˆ)TK(y − xβˆ)
2σˆ2
and
P0 = I −X(XTX)−1X
where βˆ and σˆ are estimated under the standard linear model with covariates only.
Under the null hypothesis, the quantity (y−xβˆ) converges to a standard normal, thus Q,
quadratic in (y − xβˆ), is distributed κχ2ν , a scaled mixture of χ2, and κ and ν are calculated
using one of several methods. We typically use the moment matching method described by Liu
et al. (2009), although other chi-square approximation methods are available (Satterthwaite,
1946; Davies, 1980; Duchesne and Lafaye De Micheaux, 2010).
Satterthwaite approximates the null distribution with the following:
κ = I˜ττ/2˜
ν˜ = 2˜2/I˜ττ
where
I˜ττ = Iττ − Iτσ2I−1σ2σ2ITτσ2
Iττ = tr{P0K(ρ)}2/2
Iτσ2 = tr{P0K(ρ)P0}/2
Iσ2σ2 = tr{P 20 }/2
˜ = tr{P0K(ρ)}/2
Liu uses moment matching to approximate a non-central chi square χ2l (δ), while the Davies
method inverts the characteristic fuction.
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To generate the p-value, Q is compared the null distribution of
P
1/2
0 KP
1/2
0
2
When the outcome is continuous:
P0 = I − X˜(X˜T X˜)−1X˜T
When the outcome is case/control:
P0 = D0 −D0X˜(X˜TD0X˜)−1X˜TD0
Where X is a matrix of covariates including intercept; and D0 is a diagonal matrix of pˆj(1−pˆj),
where pˆj is the predicted proportion of rare alleles for variant j and is estimated from logistic
regression of X on Y.
2.1.6 Combination based sequence association tests
We have thus far described 5 tests used for rare variant association testing, and there are
numerously many more to choose from as well. The investigator must choose one from these
many options before testing the data. A second choice that the investigator must make is
what will be defined as a rare variant. Choices of rare variants thresholds include variants 3%
MAF, 1% MAF, or 0.5% MAF. Additionally, the investigator may want to restrict to a set
of only non-synonymous mutations, or those that are biologically predicted to be ”harmful”
by Polyphen-2 or other software. The result is that the investigator has many tests to choose
from and many groupings to choose from as well, creating a very large set of combinations.
The necessary questions are: 1) Which is the most powerful test to use for a given data
set, and 2) Which is the best grouping to test? The answer to those questions requires a priori
knowledge of which variants are causal and what is their effect size and direction. However,
knowing this information would make testing unnecessary. As a solution, one may choose to
apply all tests and grouping and report the best p-value, but this clearly leads to inflated
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type I error.
A final class of gene sequence association tests attemps to solve the problem by combining
several tests at once in order to have power in a range of scenarios. The variable threshold
test (Price et al., 2010), for example, starts with a foundation of the score test based on
the likelihood function. However, instead of picking a fixed threshold of say 3% minor allele
frequency, they select a range of different minor allele frequency thresholds. The score test is
computed at each threshold, and a final p-value is found through permutation, so that type
I error is conserved.
Optimal tests for rare variant effects in sequencing association studies (SKAT-O) (Lee
et al., 2012), on the other hand, tests over a range of tests that spans from the count test to
the SKAT test. That is, it tests on one hand that effect sizes and directions of the various
rare alleles are perfectly corrlelated, and also the other hand that there is no correlation in
effect sizes. Scenarios in between are tested as well. Thus, while KSKAT may be written:
KSKAT = ZwZ
T
w
SKAT-O can be expanded as:
KSKAT−O = ZwRρZTw
Where Zw is the weighted minor allele frequency design matrix, and Rρ is the corellation
matrix indexed by ρ where:
Rρ = (1− ρ)I + ρ11T
Lee et. al use the minimum p-value as the test statistic and the final p-value is found by
integrating the distribution function of the null mixture of χ2 distribution.
An additional combination test was introduced by Lin and Tang (2011). The general
framework allows not only test a range of MAF thresholds, but is also capable of handling
covariates without the need for permutation.
Lin’s score statistic is:
Uk =
n∑
i=1
(
Yi − e
Yˆi
1 + eYˆi
)
ξTk ZiV
−1/2
k
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Method Comments
CAST/CMC powerful when effects of equal size/direction
Count powerful when effects of equal size/direction
Weighted Sum Test powerful when effects of equal size/direction
C-Alpha best when effects of different size/direction
SKAT best when effects of different size/direction
VT powerful over range of MAF thresholds
SKAT-O powerful for both equal or different size/direction
EREC powerful for both equal or different size/direction
Table 2.1: Summary of commonly used statistical methods of testing whole genetic sequencing
regions
where Yˆi is estimated under the null (covariates only), ξk is a kernel specific weight function,
and Vk is the kernel specific variance of the score statistic.
Lin shows that the for the optimal kernel choice, ξj = βj . To attempt to achieve optimality,
he introduced estimated regression coefficients (EREC).
EREC:
ξj = βˆj ± δ
Where δ is a given constant, and βˆj is the regression coefficient estimated from the data.
ξj will converge to βj if δ decreases to 0 as the sample size n increases to N
2.2 Statistical methods for working with missing covariates
2.2.1 Mechanisms of missingness
Covariates are important to all statistical anlaysis. They can increase power when properly
used, and can lead to inflated type I error when improperly used or ignored. In this section,
we discuss the methods used to address partially missing covariates.
Assume we have the following data set where x2 but not x1 has missingness. It is
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convenient to assign the value ri to 1 if x2i is observed and to 0 if x2i is unobserved (N/A) .
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 N/A 0
y4 x14 x24 1
y5 x15 N/A 0
...
...
...
...
yn x1n x2n 1
There are, in general, three missing data mechanisms, that is, three underlying models which
predict which data points are missing. Data missing completely at random (MCAR) is
randomly missing, that is, not predictable by any observed or unobserved data points. Data
missing at random (MAR) may be missing in a way predictable by observed data points, but
is not predictible by unobserved data points. Data not missing at random (NMAR) may be
predictable by data observed or unobserved.
To summarize with our data set, again assuming x2 but not x1 has missingness:
Missing completely at random:
R ⊥ f(y, x1, x2)
Missing at random:
R ⊥ f(x2|y, x1)
Not missing at random:
R = f(x2|y, x1)
where f(x2|y, x1) is a non-trival function
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2.2.2 Complete case
Complete case is a very simple method used where all observations with at least one
missing covariate are excluded from analysis. Complete case transforms the incomplete data
set to a complete data set which is more convenient to work with:
Complete case:
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 N/A 0
y4 x14 x24 1
y5 x15 N/A 0
...
...
...
...
yn x1n x2n 1
−→
Y X1 X2
y1 x11 x21
y2 x12 x22
y4 x14 x24
...
...
...
yn x1n x2n
It is clear, however, that complete case will result in reduced power due to the decrease in
sample size. Additionally, statistical inference on the full data using only the complete case is
invalid under MAR and NMAR. Bias is likely to result (Little and Rubin, 1987; Knol et al.,
2010).
2.2.3 Single and multiple imputation
Single imputation (SI) attempts to recover observations by filling in the missing covariate
with any number of prespecified pseudo-observations. The fill-in may be the mean or it may
be a random value based on the empirical distribution of the covariates. A posterior mean
may also be used conditional upon observation specific data and covariates.
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Single imputation using mean to fill in missing observations:
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 N/A 0
y4 x14 x24 1
y5 x15 N/A 0
...
...
...
...
yn x1n x2n 1
−→
Y X1 X2
y1 x11 x21
y2 x12 x22
y3 x13 x2
y4 x14 x24
y5 x15 x2
...
...
...
yn x1n x2n
Multiple imputation (MI) is a variation on single imputation. In multiple imputation, many
data sets are generated from the one original set, and in each set, missing values are replaced
with random values based on the emperical distribution. The statistical model is applied
independently to each created set. Finally, the predicted coefficients are averaged across the
imputed data sets to generate the final coefficients.
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Multiple imputation using random values based on the empirical distribution:
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 N/A 0
y4 x14 x24 1
y5 x15 N/A 0
...
...
...
...
yn x1n x2n 1
−→
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 x2 +  0
y4 x14 x24 1
y5 x15 x2 +  0
...
...
...
...
yn x1n x2n 1
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 x2 +  0
y4 x14 x24 1
y5 x15 x2 +  0
...
...
...
...
yn x1n x2n 1
Where  ∼ N(0, σˆ2x2) assuming x2 is normally distributed.
Imputation has an advantage over complete case in that data is not thrown away. This
clearly will increase power simply due to increased sample size. The two examples shown are
valid under MCAR (Little and Rubin, 1987). Imputation is unbiased under MAR only when
full likelihood posterior distribution used to fill-in missing data.
2.2.4 Maximum likelihood
Maximum likelihood (ML) can also be used to avoid the problem of discarding data. Here,
a distribution is given to the missing data and the resulting likelihood is integrated across all
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possible values of the missing covariate.
Maximum likelihood:
when x2 is observed:
p(yi, x2i, ri|x1i, β, α, ω) = p(yi|x1i, x2i, β)p(x2i|x1i, α)p(ri|yi, x1i, ω)
while for missing x2 (continuous):
p(yi, ri|x1i, β, α, ω) = p(ri|yi, x1i, ω)
∫
x2i
p(yi|x1i, x2i, β)f(x2i|x1i, α)dzi
or for missing x2 (discrete):
p(yi, ri|x1i, β, α, ω) = p(ri|yi, x1i, ω)
∑
x2i
p(yi|x1i, x2i, β)p(x2i|x1i, α)
In summary, the log-likelihood is:
ri log [p(yi, x2i, ri|x1i, β, α, ω)] + (1− ri) log [p(yi, ri|x1i, β, α, ω)]
which can be solved throught either the Newton-Raphson method or by the Expectation-
Maximization (EM) algorithm.
ML leads to unbiased results under MAR if the model is correctly specified. This is a clear
advantage over complete case and over most cases of imputation. An additional advantage of
ML over imputation is that ML produces the same result each time, while MI (as well as SI
with errors) leads to differing results because of the variability of the imputed data.
2.2.5 Weighted maximum likelihood for data with missing covariates
Ibrahim (1990) proposed a weighted maximum likelihood to solve the above problem.
This is very helpful when the above likelihood does not lend itself to a closed form. In
Ibrahim’s method, missing observation are expanded to multiple pseudo-observed observations
and weighted according to their posterior probability of being observed. In the following
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simple example, the covariate is dichotomous:
Y X1 X2 R
y1 x11 x21 1
y2 x12 x22 1
y3 x13 N/A 0
y4 x14 x24 1
y5 x15 N/A 0
...
...
...
...
yn x1n x2n 1
−→
Y X1 X2 w
y1 x11 x21 1
y2 x12 x22 1
y3 x13 0 pi0
y3 x13 1 pi1
y4 x14 x24 1
y5 x15 0 pi0
y5 x15 1 pi1
...
...
...
...
yn x1n x2n 1
where pi0 = 1− pi1 = P (x2 = 0|yi, x1i); and generally for missing x2i:
wi =
p(yi|x1i, x2i, β)p(x2i|x1i, α)∑
x2i
p(yi|x1i, x2i, β)p(x2i|x1i, α)
while wi = 1 for non-missing x2i.
Following Ibrahim, the expressions take the form of a weighted complete data log-likelihood
based on N =
∑n
i=1 ki observations, where ki is the number of distinct covariate patterns for
observation i. Thus, iteratively reweighted least squares (IRLS) is used in conjunction with
the Newton Raphson algorithm to solve for β and α. This Newton-Raphson algorithm is
considerably more convenient when maximum likelihood cannot be solved in closed form;
there is no sum or integral.
When the missing covariate is continuous, Ibrahim et al. (2004) suggest approximating
f(x2i|x1i) by a discrete distribution and then monte carlo is used to select L distinct points
from the distribution along with the corresponding probabilities. Weights are then generated
similar to the discrete method, and the weighted complete data log-likelihood is evaluated in
the same way.
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Method Missingness Advantage
Complete Case MCAR simple to implement
Imputation MCAR, MAR simple to implement,
uses all data
Maximum likelihood MCAR, MAR consistent results with correctly specified model
uses all data
Weighted ML MCAR, MAR consistent results with correctly specified model
by IRLS convenient form
uses all data
Table 2.2: Summary of methods to account for missing covariates. Imupation valid under
MAR only when full likelihood posterior distribution used to fill-in missing data.
2.3 Statistical methods of selecting rare genetic variants within a genetic region
2.3.1 Variable Selection
Variable selection is the practice of selecting the subset of variables which best predicts
the outcome. In most situations, this is beneficial to simplify a statistical model for a number
of reasons. It is a simpler model to explain to others. The best and simplest model has
the least variabilty in a subsequent data set. Also, during data collection, it is less costly to
record fewer variables.
In our particular setting, we first discover a genomic region that is believed to be associated
with the outcome by utilizing a region-based tests. It has now become necessary to find which
of the specific variants within the region are the ones responsible for the association. It is the
general inherent belief that some genetic variants are detrimental, some fewer are protective,
and that many have absolutely no effect at all. Because of the prior belief that many variants
have zero effect, we practice variable selection to find the variants that do have an effect or
association and that are predictive of the outcome in a future data set. This is the second
step in genetic sequence association testing.
Assuming exponential family:
g(y) = αX + βZ
zj ∈ S ⇔ βj 6= 0
We wish to identify all zj : zj ∈ S because they are the variants that are predictive
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of the outcome in a future data set. It is true that some variants not belonging to S may
be associated with the outcome through colinearity with predictive variants. These variants
would also be helpful in pointing us toward a true biological phenomenon.
Many variable selection procedures are particularly well suited, as they assume most of
the variables have no effect and a small subset of variable may have a non-zero effect on the
outcome. This leads to easier model interpretation and greater power to detect effects.
Common examples of variable selection procedures include the Lasso (Tibshirani, 1996)
and forward or backward stepwise subset selection. Many other simple statistical procedures
could be applied toward variable selection as well. For example, one could apply a standard
procedure and apply a pre-specified cutoff for effect size or p-value.
2.3.2 Univariable linear model
The simplest variable selection procedure is the univariable model. Here each genetic
variant is tested for marginal association independently of the other variants. One may use
generalized linear model or generalized linear mixed model to generate a p-value associated
with each variant and then apply a multiple comparison correction to generate a list of
statistically significant associations.
2.3.3 Multivariable linear model
Another classic way of testing is the multivariable model where all variants are tested
together in a single model and then multiple comparison correction is applied to each of the
p-values. One main difference between univariate and multivariate is that the multivariate
may miss some variants that are masked due to high corellation with another variant in the
model. The univariate does not suffer from this problem.
The advantage of the multivariate model, though, is that it is possible to use forward
and backward stepwise selection. However, forward and backward stepwise selection should
be used with caution as the theory is not developed. P-values and coefficients should be
interpreted liberally.
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2.3.4 Penalized linear regressions
A special class within the multivariable linear model are the penalized regressions. Among
these, the Lasso is particularly attractive because it inherently sets the effect size of most the
variables to zero, and the remaining few to non-zero. It is also computationally fast. The
penalization term is customarily optimized by 10-fold cross-validation.
Lasso penalizes the sum of absolute values of regression coefficients:
n∑
i=1
||g(yi)−Xiβ||2 + λ
m∑
j=1
||βj ||1
The following are other penalized regressions, which also tend to limit the number of variables
in the model:
1. Akaike information criterion (AIC) (Akaike, 1974), and Bayesian information criterion
(BIC) (Schwarz, 1978) penalize the number of parameters in the model, thus clearly performs
variable selection:
n∑
i=1
||g(yi)−Xiβ||2 + λ
m∑
j=1
||βj ||0
where λ is a constant for AIC, and λ is proportional to the sample size for BIC.
2. Ridge regression (Hoerl and Kennard, 1970) penalizes the sum of squares of regression
coefficients and thus scales parameters instead of scaling to zero.
n∑
i=1
||g(yi)−Xiβ||2 + λ
m∑
j=1
||βj ||2
3. Elastic Net (Zou and Hastie, 2005), a combination of ridge and lasso, penalizes both the
the absolute value and square of regression coefficients, thus can perform both selection and
scaling depending on weight of λ1 and λ2:
n∑
i=1
||g(yi)−Xiβ||2 + λ1
m∑
j=1
||βj ||2 + λ2
m∑
j=1
||βj ||1
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2.3.5 Consistent LASSO-based procedures
Fan and Li (2001) contend that a good penalty function should should produce an
estimator with the following properties : Unbiasedness, sparsity, and continuity. The Lasso
estimates are sparse and continuous, and Lasso is in fact the only sparse and continuous
penalty within the family of λ|β|q, for some q. That is, q=1 is the only q which produces
sparse and continuous estimates. AIC and BIC achieve sparsity but are not continuous in β.
Ridge regression is continuous but do not achieve sparsity. However, Lasso is not unbiased,
as large coefficients are estimated with a biased shift toward 0 equal to a constant. Fan and
Li (2001) in turn propose the smoothly clipped absolute deviation (SCAD) penalty that has
all three of the desirable qualities.
SCAD:
pλ(β; a) =

λ|β|, |β| <= λ
−(β2 − 2aλ|β|+ λ2)/[2(a− 1)], λ < |β| <= aλ
(a+ 1)λ2/2, |β| > aλ

for some a > 2 and λ > 0
Additionally, the adaptive Lasso by Zou (2006), through adaptive weighting, achieves
consitent, unbiased estimates.
Adaptive Lasso
pλ(θ) = λ
m∑
j=1
wj ||βj ||1
with wj = 1/|βˆj |γ estimated under ordinary least squares with γ > 0.
Finally, Bolasso, through bootstrap (Bach, 2008; Chatterjee and Lahiri, 2011), achieves
asymptotically consistent, unbiased estimates. The algorithm begins by applying Lasso to m
bootstraped samples of the data. The union of variables with non-zero coefficients in at least
one bootrapped Lasso are compiled. These variables only are modeled using non-penalized
regression for final parameter estimation.
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2.3.6 Stability Selection
Although Lasso has the attractive property of shrinking coefficients to 0, it has a disadvantage
in that there is no way to control type I error. Meinshausen and Bu¨hlmann (2010) proposed
stability selection to address this concern. In their procedure, B bn/2c subsamples out of n
total observations are selected and applied to Lasso.
pˆk,n/2,B =
1
B
B∑
b=1
I(k ∈ Sˆn/2,b)
The variable is selected as significant if pˆk,n/2,B ≥ pithr (we set to 0.75) proportion of the B
subsamples applied to Lasso.
They obtain a bound on family-wise error by making two assumptions: 1. Selection
procedure no worse than guessing; and 2. All non-associated variants selected with equal
likelihood.
FWER =
1
2pithr − 1
q2Λ
m2
where qΛ is the number of variables selected by Lasso. The weak assumptions result in a
bound that is quite conservative. Current research (Shah and Samworth, 2012) is directed
toward tightening this bound.
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Method Comments
Univariate well developed theory
Multivariate well developed theory, possible masking due to correlation
Forward/Backward Selection undeveloped theory
AIC/BIC variable selection
Lasso inherently shrinks many effects to zero, but no type I error
Ridge Regression scales parameters
Ridge Regression scales and shrinks parameters
Adaptive Lasso asymptotically consistent
SCAD asymptotically consistent
Bolasso asymptotically consistent
Stability Selection type I error with Lasso
Table 2.3: Summary of methods of variable selection
26
Chapter 3
Rare Variant Testing Across Methods and Thresholds Using the Multi-Kernel
Sequence Kernel Association Test (MK-SKAT)
3.1 Introduction
Identification of genetic variants influencing complex phenotypes and disease is a major
goal of modern human genetics research. So far, despite the success of genome wide association
studies (GWAS)(Hindorff et al., 2009), newly discovered trait-associated genetic variants
still fail to explain a large proportion of the heritability of complex traits (Eichler et al.,
2010). It is hoped that with the advent of accessible DNA sequencing technology (Margulies
et al., 2005; Mardis, 2008; Ansorge, 2009), investigators can uncover more of the so-called
missing heritability. Some of the added information contained in sequencing data includes
rare variants, that is variants with minor alleles whose population frequency is low. This
contrasts with microarray technology which typically focuses on common variants that have
relatively high minor allele frequency (MAF). Rare variants associated with disease have
already been reported (Cohen et al., 2006; Walsh et al., 2008; Nejentsev et al., 2009). However,
important distinctions between the analysis of common variants and rare variants must be
made (Carvajal-Carmona, 2010). Most importantly, the standard analysis of common variants
focuses on analysis of each individual variant, one-by-one. Yet, power decreases with lower
MAF such that standard approaches for common variants are vastly underpowered for analysis
of rare variants. Also, multiple comparison corrections are a concern since the number of
variants is dramatically larger.
To address the limitations of using standard analytical approaches for variants, investigators
have turned to region based approaches for rare variant association testing. In this class of
approaches, all variants within a region, typically a biologically meaningful unit such as a
single gene or an exon, are simultaneously considered together. The cummulative effect of
the entire group of variants, or more often a subgroup of the variants (e.g. those with MAF
<1%), is assessed for association with the phenotype. Grouping the variants and testing only
the cumulative effect addresses the low signal concern by amplifying across several variants.
It also addresses the multiple comparison correction concern by substantially decreasing the
number of tests performed. A wide range of methods have beeen developed with varying
characteristics and underlying principles (Morgenthaler and Thilly, 2007; Li and Leal, 2008;
Morris and Zeggini, 2010; Madsen and Browning, 2009; Neale et al., 2011; Wu et al., 2011).
Despite the sucess of current approaches for rare variant testing (Cohen et al., 2006; Walsh
et al., 2008; Nejentsev et al., 2009), a number of practical concerns have arisen. In particular,
given the wide range of testing approaches which are optimized toward different scenarios, it
is unclear which method to use for any particular data set. Furthermore, it is unclear which
strategy to use for grouping variants, e.g. grouping variants with MAF <3% vs <1%, within
a region. Unfortunately, the answer to both questions depends on the underlying true state
of nature which is unknown prior to analysis. Knowledge on this would preclude need for
analysis. Selecting the “best” (often most significant) result after conducting analyses using
multiple methods or multiple group strategies would lead to severely inflated type I error
and increased false positives. Although some recent work has been done on omnibus testing
across different grouping strategies (Price et al., 2010; Lin and Tang, 2011) or across different
testing approaches (Lee et al., 2012), few methods consider both the testing approach and
the grouping strategy simultaneously.
To address this problem, we propose the multi-kernel sequence kernel association test
(MK-SKAT). In this article, we show that many commonly used testing approaches are
equivalent to particular cases of the sequence kernel association test (SKAT). SKAT is
a similiarity based analysis approach for rare variant testing wherein pair-wise similarity
between individuals based on their rare variant profiles is measured via a kernel function and
then compared to pair-wise similarity in phenotype. Specifically, the currently used methods
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are equivalent to versions of SKAT using different kernel functions. We further show that
different choices of grouping strategies are also equivalent to using the SKAT with different
kernel functions. Consequently, the question of selecting a test to use as well as selecting a
grouping strategy reduces to the problem of selecting an appropriate kernel function. This
equivalence then leads to natural application of perturbation based procedures for omnibus
testing across multiple kernels (and accordingly multiple grouping and rare variant testing
approaches) (Wu et al., 2013). We conduct computer simulations and a real data applicaton
to validate our approach and show that our proposed method loses a small amount of power
when compared to the optimal grouping and testing approach, but offers considerably more
power over poor choices.
The remainder of this paper is organized as follows. In the next section, we first review the
generic SKAT method and describe how different testing approaches and different groupings
all correspond to SKAT under different kernels. We then present the proposed MK-SKAT
approach for testing across different tests and groupings. We show results from some representative
simulation studies and from an illustration of our approach on real data. We conclude with
a brief discussion.
3.2 Methods
Within this article, we describe our methodology within the context of analyzing a single
gene region. However, the approach can be applied to multiple regions separately, with
appropriate control for multiple comparisons. We let yi denote the phenotype for the i
th
individual in the study (i = 1, . . . , n), and Xi be a vector of environmental or demographic
variables for which we would like to adjust. For dichotomous phenotypes we let yi = 0 or 1
for controls and cases, respectively. For each given region, we let Zi be the vector of genetic
variants within the region coded under the additive model. The objective is to test for an
association between y and all the variants in Z or a subset of the variants in Z while adjusting
for X. We let G denote the indices of the variants within Z that we would like to test. For
instance G may be the indices of the variants with MAF < 1% or the nonsynonymous variants.
In doing so, one may select a subset of the variants in the region to test or one may test a
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subset of the variants. Clearly, restricting attention to the truly causal variants would result
in the higest power; however, which variants are causal is unknown. At the same time, there
are a range of tests to choose from. Determining which group of variants to test and which
test to use poses a grand challenge for geneticists.
In this section, we first review the SKAT method and draw connections between SKAT
and several other important tests. We describe how the questions of which test to use and
which variants to test can be recast as a question of kernel choice. We then develop the
MK-SKAT to construct an omnibus test that simultaneously considers multiple tests and
grouping strategies.
3.2.1 Connections between SKAT and other Methods
SKAT
SKAT is a similarity based test that operates by comparing pair-wise genotypic similarity
between individuals to pair-wise phenotypic similarity, with correlation suggestive of association.
Mathematically, SKAT uses the linear model for quantitative traits
yi = α0 + X
′
iα+ h(ZGi) + εi
and the logistic model for case/control studies
logitP (yi = 1) = α0 + X
′
iα+ h(ZGi)
where α0 is an intercept term, α is the vector of regression coefficients for the covariates,
and εi has mean zero and variance σ
2. The variants of interest ZGi for the i-th individual
are related to the outcome only through the function h(·) which is a general function lying
in a functional space generated by a positive definite kernel function K(·, ·). Intuitively,
K(ZGi ,ZGi′ ) measures similarity between i-th and i
′-th individuals in the study based on ZG ,
the variants of interest. This function fully specifies the relationship between the variants and
the outcome. If one sets K(ZGi ,ZGi′ ) = Z
′
GiZGi′ , which is the linear kernel, then this implies
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that the function h(ZGi) =
∑
j∈G βjZij , i.e. h(·) is linear and the outcome depends on the
variants in a linear manner. By specifying a different kernel, one may specify an alternative
model. Under the default SKAT parameters, K(ZGi ,ZGi′ ) =
∑
j∈G w
2
jZijZi′j where wj is
equal to a the beta probability density function with parameters 1 and 25 evaluated at the
MAF for the j-th variant. Also by default, G is set to be the entire group of both common
and rare variants within a region. This corresponds to a linear model but with additional
up-weighting for the effect of rarer variants.
To test the effect of the rare variants under SKAT corresponds to testing H0 : h(ZG) = 0.
Defining the kernel matrix, K, to be the n-by-n matrix with i, i′-th term equal to K(ZGi ,ZGi′ ),
for quantitative traits, we construct the variance component score statistic
Q =
(y − ŷ)′K(y − ŷ)
σ̂2
where ŷ = α̂0 + Xα̂ with α̂0, α̂, and σ̂ estimated under H0. For dichotomous traits, we can
construct a similar score statistic
Q = (y − ŷ)′K(y − ŷ)
where ŷ = logit−1(α̂0 + Xα̂) and α̂0, α̂ are again estimated under H0. To obtain a p-value
for significance, asymptotically, Q ∼ ∑λjχ21 is a mixture of chi-squared distributions, with
weights λj equal to the eigenvalues of P
1/2
0 KP
1/2
0 where P0 = D−DX(X′DX)−1X′D with
D = I for quantitative traits and D = diag{ŷi(1 − ŷi)} for dichotomous traits. This null
distribution can be approximated using moment matching approaches (Liu et al., 2009) or
exact methods (Davies, 1980).
Existing Methods and Grouping Strategies as Special Cases of the SKAT
A wide range of region-based analysis approaches of rare variants have been proposed.
Generally, however, they tend to fall within two classes: burden-based approaches and
similarity-based approaches. Burden-based tests generally operate by collapsing the rare
variants within a region into a single value using (possibly weighted) averaging and then
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testing for association by regressing the phenotype on the collapsed variable or applying
appropriate permutation-based approaches. Letting G denote the indices of the rare variants
over which we would like to collapse, then the cohort allelic sum test (CAST) and combined
multivariate collapsing (CMC) collapses the genetic variants within a region to a single binary
variable
Ci = I
 p∑
j∈G
Zij > 0

which is an indicator for whether the ith individual has any rare variants within the region.
In a slight variation, the count-based collapsing method computes the collapsed variable as
Ci =
p∑
j∈G
Zij
which is the total number of rare variants within the region. To place a higher weight on
variants which are rarer, the weighted count collapsing method collapses the variants in G
into
Ci =
p∑
j∈G
wjZij
where wj is a weight for the j
th variant which is inversely related to the MAF for the jth
variant. To test whether the rare variants are related to the phenotype, the outcome is
regressed on the collapsed variable and possible covariates using the models
yi = α0 + X
′
iα+ βCCi + εi
or
logitP (yi = 1) = α0 + X
′
iα+ βCCi
for quantitative and dichotomous traits, respectively. Testing for the rare variant effect then
corresponds to testing H0 : βC = 0 which can be done using a standard 1-df test. The burden-
based rare variant association tests are similar in that they sum over all of the rare variant
genetic information. Thus, they are most powerful when the effects of the variants are truly
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associated with the outcome and with common direction of effect, that is, all variants are
deleterious or all variants are protective. Power is lost when effects are opposite in directions
or non-causal variants are included in G.
Similarity-based tests were proposed to address the power loss due to variants with
opposing effects. This class includes SKAT, and compares pair-wise similarity between
individuals in terms of their genotype values to pair-wise similarity in phenotype, with
correlation suggestive of association. Also included within this class is the C-alpha test which
tests for an over-dispersion of the variance resulting from a rare variant effect rather than a
change in the mean effect. By testing variance rather than net effect, the test is powerful to
detect genetic association when the effects of the variants are not all in the same direction.
It has been previously noted that individual tests are equivalent to SKAT under particular
kernel functions(Wu et al., 2011; Lee et al., 2012). For example, the C-alpha test is equivalent
to SKAT using the kernel function K(ZGi ,ZGi′ ) =
∑
j∈G ZijZi′j . Further, each of the burden
based methods operate by using a univariable summary of the rare variants in G such that
the outcome is a simple linear function of the collapsed variable Ci. Therefore, each of the
CAST/CMC, count-based collapsing, and weighted count-based collapsing can be viewed as
SKAT with a linear kernel constructed based on the collapsed variable. Thus we have the
following tests and corresponding kernels:
• (Default) SKAT: K(ZGi ,ZGi′ ) =
∑
j∈G wjZijZi′j
• C-alpha: K(ZGi ,ZGi′ ) =
∑
j∈G ZijZi′j
• CAST (Binary Collapsing): K(ZGi ,ZGi′ ) = I
(∑p
j∈G Zij > 0
)
I
(∑p
j∈G Zi′j > 0
)
• Count-Based Collapsing: K(ZGi ,ZGi′ ) =
{∑p
j∈G Zij
}{∑p
j∈G Zi′j
}
• Weighted Count-Based Collapsing: K(ZGi ,ZGi′ ) =
{∑p
j∈G wjZij
}{∑p
j∈G wjZi′j
}
Given that many individual tests reduce to SKAT under different kernel, then the problem
of choosing a particular test reduces to the problem of choosing a particular kernel.
We have, thus far, focused on testing the variants in a particular group, G. In practice
however, one must also choose, a priori, a group of variants to test. For example, one may
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apply each of the tests to all of the variants in the region or one could restrict the variants
of interest to just the variants with <3% MAF, < 1% MAF, or <0.5% MAF, depending on
how one wishes to define “rare”. Additionally the investigator may want to restrict to a set
of only non-synonymous variants or those that are predicted to be “harmful” by Polyphen-2
(Adzhubei et al., 2010) or other software for predicting function. Use of different choices of
variants can easily be translated into a problem of kernel choice by simply restricting G to
be different sets of variants. For example, we can define G3% to be the variants with MAF <
3% and G0.5% to be the variants with MAF < 0.5%. Then if we are interested in the C-alpha
test, we can apply it to the variants with MAF < 3% or < 0.5% by constructing the kernels
K(ZG3%i ,ZG3%i′
) =
∑
j∈G3% ZijZi′j and K(ZG0.5%i ,ZG0.5%i′
) =
∑
j∈G0.5% ZijZi′j , respectively and
test using the usual SKAT procedure. Therefore, it follows that the problem of choosing
which group of variants to test also reduces to the problem of choosing a particular kernel.
3.2.2 Multi-Kernel Sequence Kernel Association Test
The questions facing researchers interested in rare variant analysis are first, which is
the most powerful test to use for a given data set, and second, which is the best group of
variants to test within a particular region? As noted earlier, these questions can be reduced
to a question of kernel choice: which kernel, from among a group of candidates, will yield
highest power? Despite transforming the problem, the answer to this question requires prior
knowledge of which variants are causal and what is their effect size and direction, knowledge
which is rarely available (since this would preclude the need for analysis). As a solution, one
may choose to test under all candidate kernels and report the best p-value, but this clearly
leads to inflated type I error. However, by exploiting the connections between SKAT and
other tests, we propose a solution that incorporates many tests and groupings but conserves
type I error through the use of perturbation.
Our proposed unifying method, the multiple kernel SKAT (MK-SKAT), simultaneously
several test and variant grouping choices at once and constructs an omnibus test. The idea
behind the approach is that it constructs kernels based on each candidate test and grouping
approach. For example, one may test using CAST, count-based collapsing, C-alpha, and the
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defaul SKAT with 3 grouping strategies per test (MAF <3%, <1%, or <0.5%) for a total of
12 combinations corresponding then to 12 candidate kernels. MK-SKAT then conducts an
omnibus test across all of the candidate kernels, by applying SKAT with each of the kernels,
taking the minimum p-value, and then applying perturbation base techniques to correct for
having taking the minimum p-value. A single p-value is reported. This represents a simplified
version of the omnibus testing strategy of Wu et al. (2013).
The intuition behind the procedure is that asymptotically σ̂−1(yi−ŷi) will be approximately
normal such that we can replace it with a simulated normal random variable. Using the same
simulated normals for each candidate kernel allows for capture of the correlation between
tests. The full MK-SKAT procedure is as follows:
1. For each combination of candidate testing procedure and each candidate grouping
procedure, construct a corresponding kernel matrix, K`, to obtain a total of L candidate
kernels.
2. Using each candidate kernel, K`, obtain a corresponding score statistic as Q` and p-value
for significance p`.
3. Find the minimum p-value: pmin = min1≤`≤L p`
4. For ` ∈ 1, . . . , L, compute Λ` = diag(λ`,1, . . . , λ`,m`), and V` = [v`,1,v`,2, . . . ,v`,m` ]
where λ`,1 ≥ λ`,2 ≥ . . . ≥ λ`,m` are the m` positive eigenvalues of P1/20 K`P1/20 with
corresponding eigenvectors v`,1,v`,2, . . . ,v`,m`
5. Generate r∗ = [r∗1, r∗2, . . . , r∗m]′ with each r∗j ∼ N(0, 1). Note that m = max1≤`≤Lm` is
the maximum number of nonzero eigenvalues across the candidate kernels and may be
less than n.
6. For each ` ∈ 1, . . . , L, rotate r∗ using the eigenvectors to generate r∗` = V`r∗.
7. Can then compute Q∗` = r
∗
`
′Λ`r∗` for each ` and obtain a corresponding p-value, p
∗
` , by
comparing Q∗` to the distribution function estimated for Q` and obtain the upper tail
probability exceeding Q∗` . We set p
∗ = min1≤`≤L p∗` .
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8. Repeat (5)-(7) B times to obtain p∗(1), p
∗
(2), . . . , p
∗
(B) for some large number B.
9. The final p-value for significance is estimated as
p = B−1
B∑
b=1
I(p∗(b) ≤ pmlin)
It is important to note that direct use of the p-value is necessary rather than using the
maximum score statistic since the raw score statistics have different degrees of freedom.
Although this strategy also generates a monte carlo p-value, there are two advantages.
First, covariates and variants can be correlated. In contrast, in order for permutation to be
valid, the variants must be uncorrelated with the covariates. Second, the MK-SKAT procedure
is more computationally efficient since the computation now relies only on generating and
then rotating m normal random variables while all other parameters remain the same. In
contrast, permutation requires complete re-estimation of the kernel matrices, P0 matrices,
eigendecompositions, and distribution parameters.
This method assumes nested kernels. Although CAST is not nested, being non-linear
in nature, the rarity of genetic variants being considered allows the kernel to be considered
approximately linear. Additionally, MK-SKAT is conservative, so any anit-conservativeness
resulting from the approximation is mitigated.
We note that this procedure is closely related to the general perturbation procedure
previously used for testing across multiple kernels Wu et al. (2013). However, because each
of the kernels used in this scenario for rare variant analysis is essentially a generalization of
a weighted linear kernel, then they all lie within a common column space thereby simplifying
the procedure.
3.2.3 Simulations
We conducted a series of computer simulations to verify that the proposed MK-SKAT
procedure is valid in terms of controling type I error and has reasonable power compared to
the individual tests across which the MK-SKAT is combining.
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Type I Error
To demonstrate that the proposed methods are valid tests, in terms of protecting type
I error, we conducted a series of simulations under null models for both continuous and
dichotomous traits. We used a coalescent model to simulate a region with 100 variants in
104 haplotypes with LD structure representative of a European population (Schaffner et al.,
2005). Eighty-five of the simulated variants had a true MAF less than 3% and 80 had a MAF
less than 1%. We then paired haplotypes to simulate n = 1000 or 2000 diploid individuals.
For type I error simulations, we simulated quantitative outcomes for each individual without
regard to the genotype values under the null model:
yi = 0.5Xi1 + 0.03Xi2 + εi
where Xi1 ∼ ber(0.506), Xi2 ∼ N(29.2, 21.1), and εi ∼ N(0, 1). For dichotomous outcomes,
we simulated n/2 cases and n/2 controls from the null logistic model:
logitP (yi = 1) = −4.2 + 0.5Xi1 + 0.03Xi2
where Xi1 ∼ ber(0.506) but Xi2 ∼ N(0, 1).
In total, we simulated 105 data sets as described. We applied the MK-SKAT testing
procedure to each data set. Specifically, we considered four different testing procedures:
CAST, count-based collapsing, the C-alpha, and SKAT tests. We also considerd three
different grouping strategies: we set the rare variant grouping, G, equal to the variants with
MAF < 0.5%, variants with MAF < 1%, and variants with MAF < 3%. Under the equivalence
with SKAT, this yielded a total of 12 different candidate kernels. We estimated the type I
error rate at the 0.05 level of 1) SKAT with each individual kernel, 2) MK-SKAT conditional
on a particular testing procedure (i.e. we assumed a fixed test while considering multiple
groupings), 3) MK-SKAT conditional on a particular grouping strategy (i.e. we assumed a
fixed grouping while considering multiple tests), and 4) MK-SKAT testing across all twelve
candidate kernels.
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Power
We also assessed the power of the MK-SKAT procedure under three different simulation
settings. For each setting, we again simulated haplotypes for a region containing 100 variants
as in the type I error simulations. These were then paired to generate n = 1000 individuals.
Then we simulated outcomes under the alternative model for quantitative traits:
yi = 0.5Xi1 + 0.03Xi2 + β
′Zci + εi
and for dichotomous traits:
logitP (yi = 1) = −4.2 + 0.5Xi1 + 0.03Xi2 + β′Zci
Xi1, Xi2 and εi were as before, but Z
c
i were the genotypes of the causal variants and β
were the corresponding regression coefficients which varied across simulation settings. For
dichotomous outcomes n/2 subjects were sampled as cases with the remaining n/2 set as
controls.
Under Setting 1, we considered a quantitative outcome with 50% of the variants with true
population MAF < 1% randomly selected to be causal. All causal variants were given the
same effect with β = 0.5. Since a large proportion of the variants were causal and they all
had the same effect, this scenario favored the burden approaches and particularly count based
collapsing.
Setting 2 again examined quantitative traits and was identical to Setting 1 except the
effects of the causal variants were equal to -0.5 and 0.5 with equal probability. Since the
causal variants had opposing effects, this scenario favored the similarity based tests.
Setting 3 differed from Settings 1 and 2 in that it examineed the case where the outcome
was dichotomous. Of the variants with true MAF < 3%, 20% were randomly selected to be
causal. All causal variants were again given equal effect size of β = 0.5.
We emphasize that these simulations were not intended to serve as a comprehensive
comparison of the methods across scenarios nor to understand when individual tests and
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C-alpha SKAT CAST Count MK-SKAT
n = 1000 0.5% 0.048 0.047 0.050 0.049 0.048
1% 0.048 0.049 0.049 0.050 0.050
3% 0.048 0.049 0.051 0.051 0.051
MK-SKAT 0.050 0.051 0.051 0.051 0.051
n = 2000 0.5% 0.049 0.049 0.050 0.050 0.052
1% 0.047 0.047 0.050 0.050 0.051
3% 0.047 0.047 0.050 0.049 0.051
MK-SKAT 0.052 0.051 0.052 0.051 0.050
Table 3.1: Type I error simulation results for quantitative traits. Each cell in the table
corresponds to the type I error of SKAT using a kernel constructed based on the testing
procedure at the top of the table and the grouping strategy at the left of the table. Rows
and columns labeled MK-SKAT correspond to the omnibus tests across tests (with fixed
group) and across groupings (with fixed test). The cells with both rows and columns labeled
MK-SKAT correspond to the omnibus test across all test and groupings.
grouping strategies are optimal (since this depends on the true state of nature, which is
unknown in any real data). Instead, these simulations serve to understand how MK-SKAT
behaves relative to the best method and grouping strategy.
3.3 Results
3.3.1 Type I Error and Power
Type I error simulation results for quantitative traits and dichotomous traits are shown
in Table 3.1 and Table 3.2, respectively. For quantitative traits, individual methods as well
as MK-SKAT appropriately controlled the type I error at the α = 0.05 level. However, for
dichotomous traits, the C-alpha test and SKAT test tended to be conservative, reflectiing
previous results (Wu et al., 2011). Thus, MK-SKAT tests were conservative as well.
Results of the power analysis for the 3 settings are shown in Tables 3.3 through 3.5. In
Setting 1 (Table 3.3), the count kernel applied to the variants with MAF <1% performed
the best, followed closely by the CAST kernel applied to the same grouping. This was not
surprising considering they were best adapted to the true model in which all effects have the
same size and direction, and only rare variants with MAF <1% are sampled to be causative.
The MK-SKAT which tested over all 12 kernels had power slightly less than the most powerful
single kernel. The results of the MK-SKAT testing across all 4 tests at the 1% MAF threshold
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C-alpha SKAT CAST Count MK-SKAT
n = 1000 0.5% 0.033 0.032 0.051 0.050 0.042
1% 0.042 0.040 0.050 0.049 0.045
3% 0.046 0.044 0.050 0.050 0.046
MK-SKAT 0.039 0.037 0.052 0.051 0.044
n = 2000 0.5% 0.041 0.041 0.050 0.050 0.047
1% 0.046 0.046 0.050 0.050 0.049
3% 0.047 0.047 0.050 0.050 0.050
MK-SKAT 0.047 0.045 0.051 0.051 0.047
Table 3.2: Type I error simulation results for dichotomous traits. Each cell in the table
corresponds to the type I error of SKAT using a kernel constructed based on the testing
procedure at the top of the table and the grouping strategy at the left of the table. Rows
and columns labeled MK-SKAT correspond to the omnibus tests across tests (with fixed
group) and across groupings (with fixed test). The cells with both rows and columns labeled
MK-SKAT correspond to the omnibus test across all test and groupings.
group showed power would be nearly equivalent to the most powerful single kernel as well.
Also, if one tested the count kernel over the 3 groupings, power would be conserved.
In Setting 2, power was dramatically decreased for the count and CAST kernels compared
to Setting 1 (Table 3.4). This was due to the true model having bidirectional genetic effect on
the outcome. Some rare variants increased the outcome, while some decreased the outcome.
Compared to Setting 1, power was reduced for C-alpha and linear weighted kernels, but
not to the same extent as count and CAST. C-alpha and linear weighted kernels applied to
the variants with MAF <1% performed the best in Setting 2. MK-SKAT testing over all 12
kernels displayed power somewhat less than the most powerful single kernel, but much greater
than any of the CAST or count kernels. If one applied MK-SKAT over the three groupings
of the linear weighted kernel, power would be nearly equivalent to the most powerful single
kernel. This setting clearly showed the adaptability of the MK-SKAT method under variation
in the genotype/phenotype structure.
Setting 3 compared power between methods for a dichotomous outcome (Table 3.5). The
linear weighted kernel applied to the variants with MAF <3% performed the best. They were
best adapted to the true model where only 20% of the variants were truly causal, and rare
variants with MAF <3% were sampled as causative. MK-SKAT testing over all 12 kernels had
power slightly greater than the most powerful single kernel, though this is likely to be within
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C-alpha SKAT CAST Count MK-SKAT
n = 1000 0.5% 0.43 0.43 0.64 0.66 0.64
1% 0.74 0.76 0.84 0.85 0.86
3% 0.47 0.64 0.63 0.63 0.71
MK-SKAT 0.69 0.72 0.81 0.85 0.84
n = 2000 0.5% 0.70 0.71 0.85 0.87 0.87
1% 0.92 0.93 0.98 0.98 0.98
3% 0.76 0.89 0.88 0.88 0.92
MK-SKAT 0.92 0.93 0.97 0.98 0.97
Table 3.3: Power results for Setting 1. Each cell in the table corresponds to the power of
SKAT using a kernel constructed based on the testing procedure at the top of the table and the
grouping strategy at the left of the table. Rows and columns labeled MK-SKAT correspond
to the omnibus tests across tests (with fixed group) and across groupings (with fixed test).
The cells with both rows and columns labeled MK-SKAT correspond to the omnibus test
across all test and groupings.
C-alpha SKAT CAST Count MK-SKAT
n = 1000 0.5% 0.37 0.37 0.10 0.12 0.32
1% 0.63 0.65 0.17 0.23 0.57
3% 0.39 0.54 0.13 0.16 0.46
MK-SKAT 0.60 0.63 0.16 0.23 0.55
n = 2000 0.5% 0.68 0.69 0.15 0.17 0.61
1% 0.87 0.88 0.26 0.36 0.84
3% 0.63 0.80 0.17 0.23 0.72
MK-SKAT 0.87 0.89 0.27 0.36 0.83
Table 3.4: Power results for Setting 2. Each cell in the table corresponds to the power of
SKAT using a kernel constructed based on the testing procedure at the top of the table and the
grouping strategy at the left of the table. Rows and columns labeled MK-SKAT correspond
to the omnibus tests across tests (with fixed group) and across groupings (with fixed test).
The cells with both rows and columns labeled MK-SKAT correspond to the omnibus test
across all test and groupings.
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C-alpha SKAT CAST Count MK-SKAT
n = 1000 0.5% 0.26 0.26 0.31 0.32 0.33
1% 0.53 0.55 0.52 0.50 0.59
3% 0.73 0.78 0.69 0.69 0.78
MK-SKAT 0.77 0.79 0.72 0.73 0.80
n = 2000 0.5% 0.52 0.53 0.47 0.48 0.57
1% 0.75 0.77 0.70 0.69 0.78
3% 0.84 0.88 0.82 0.80 0.88
MK-SKAT 0.90 0.91 0.85 0.86 0.91
Table 3.5: Power results for Setting 3. Each cell in the table corresponds to the power of
SKAT using a kernel constructed based on the testing procedure at the top of the table and the
grouping strategy at the left of the table. Rows and columns labeled MK-SKAT correspond
to the omnibus tests across tests (with fixed group) and across groupings (with fixed test).
The cells with both rows and columns labeled MK-SKAT correspond to the omnibus test
across all test and groupings.
the range of monte carlo error. If one applied MK-SKAT to the three groupings using either
the linear weighted or C-alpha kernel, power would nearly equivalent to the most powerful
single kernel.
Overall, results show that while protecting type I error, the MK-SKAT can achieve power
close to using the optimal test and grouping strategy. While there is generally some modest
loss in power relative to the best choice, the proposed omnibus tests offer considerably better
power than poor choices and represent a reasonable compromise. If one is able to restrict
attention to a particular group of variants based on prior information or to a particular testing
procedure based on hypotheses of the underlying model, then power can be further increased
by restricting the MK-SKAT to fewer tests or fewer groupings.
3.3.2 Data Analysis
We examined the performance of our proposed method on a real data set. Briefly, we
examined a single candidate gene containing 86 variants of which the majority had allele
frequency less than 3%. Eight variants were non-synomymous and two were predicted to be
harmful. The candidate gene was sequenced in 2000 individuals. In addition to genotype
information, we had 42 separate outcomes traits and additional demographic covariates
including age, gender and the top five eigenvalues of genetic variability. We performed analysis
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to find whether our candidate gene had association with any of the 42 outcome traits.
To illustrate our method, we considered testing using CAST, count based collapsing,
weighted count based collapsing, the C-alpha, and the default SKAT. For groupings, we
considered using all of the variants in the region, the variants with MAF <3%, variants with
MAF <1%, variants with MAF <0.5%, nonsynonymous variants, and variants predicted to
be harmful. In total we considered 27 different kernels based on combinations of the test
choice and grouping choice — the CAST, count based collapsing, and weighted count based
collapsing were not applied to all of the variants. In addition to applying SKAT with each of
the candidate kernels, we also applied the MK-SKAT testing across all 27 kernels.
Analysis results are presented in Figure 3.1. Overall, for many traits, using different
methods and different groupings resulted in very different results in terms of significance. In
general, MK-SKAT tended to yield results slightly less significant than those using the best
kernel (choice of test and grouping strategy), but MK-SKAT still performed considerably
better than poor choices of kernels.
3.4 Discussion
In analysis of genetic rare variants, given the difficulties associated with selecting a test and
selecting a particular group of variants to test, MK-SKAT allows investigators to agnostically
consider several different, popular, testing approaches as well as several different ways of
thresholding the variants. Although there is some loss of power compared to the best single
test and best grouping, the power is still considerably higher than when using a poor choice
of test or a poor choice of grouping strategy. And type I error is conserved.
Restriction of the MK-SKAT to a smaller set of possible kernels (i.e. smaller set of tests
or groupings) can yield higher power if the considered kernels are closer to the best test
and grouping strategy. If such information is available, such as through previous studies
of common variants within the region or through bioinformatics knowledge, we strongly
encourage investigators to directly restrict interest to a smaller group of candidate kernels.
On the other hand, in the absence of reliable prior knowledge, we recommend consideration
of a wide range of kernels. Importantly, if kernels are very similar to one another, then the
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Figure 3.1: Real data analysis results. Each column of circles corresponds to the p-values
from analyzing a different trait while each circle represents the p-value from a different kernel.
The triangle indicates the p-value from applying MK-SKAT to all of the kernels. p-values
have been truncated at 10−6. The blue line indicates the bonferroni significance level.
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perturbation procedure will accomodate the correlation and will not penalize the significance
as much as if the considered kernels are more different.
Interestingly, while several methods are special cases of SKAT, some other methods are
special cases of the MK-SKAT. The variable threshold test (Price et al., 2010) is equivalent
to MK-SKAT when the kernels under consideration are based on a single testing approach
with only the variable grouping being varied. However, we note that use of perturbation still
offers computational advantage over the threshold test. Similarly, the SKAT-O method (Lee
et al., 2012) is equivalent to MK-SKAT in which the variable grouping is fixed but one is
considering a range of linear combinations of SKAT and collapsing kernels.
Further methods may also fall within the MK-SKAT framework, but although many
popular tests can be considered using MK-SKAT, there are certainly many useful tests that
fall outside. For example, tests that use the outcome information in order to estimate weights
for variants (Ionita-Laza et al., 2011; Hoffmann et al., 2010; Han and Pan, 2010b) cannot be
applied. While these tests still can be considered special cases of SKAT, the kernel is now
estimated using the outcome such that standard asymptotics for SKAT and the perturbation
based techniques for MK-SKAT cannot be used to obtain p-values. Further statistical work
is needed in order to allow the MK-SKAT procedure to encompass these methods.
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Chapter 4
Accommodating Partially Missing Covariates in the Sequence Kernel
Association Test for Rare Variants
4.1 Introduction
A major focus of current human genetic research lies in the identification of genetic variants
which influence disease and other complex phenotypes. Although genome wide association
studies (GWAS) have found important associations between individual genetic variants and
complex traits (Hindorff et al., 2009), much of the heritability is still left to be discovered
(Eichler et al., 2010). DNA sequencing data promises to uncover a greater proportion of the
herditability of complex traits (Margulies et al., 2005; Mardis, 2008; Ansorge, 2009), since
sequencing allows for genotyping of not only the common single nucleatide polymorphisms
(SNP) but also rarer genetic variants, that is genetic variants with minor alleles whose
population frequency is lower. There is belief that rare variants can have larger effects on
traits and a number of rare variants associated with disease have been reported (Cohen et al.,
2006; Walsh et al., 2008; Nejentsev et al., 2009).
The interest in rare variants has spurred considerable research into new statistical and
computational methods for testing the association between rare variants and complex traits.
Since approaches for testing individual variants are often underpowered, region based testing,
wherein the cumulative effect of multiple rare variants (such as within a gene) on an outcome
is evaluated, has become the standard strategy. A wide range of region based tests have
been developed with varying attributes. A key feature of many of these tests is the ability
to accommodate covariate information. Within the context of genetic association studies, for
both common and rare variants, adjustment for covariates such as ancestry, age, gender, and
environmental variables (Laird et al., 2000; Gauderman, 2003; Lunetta et al., 2000; Purcell
et al., 2007) is essential in order to gaurd against confounding and prevent identification of
spurious findings (Little and Rubin, 1987). Covariate adjustment can also result in improved
power through reduction of the residual standard error.
While many popular rare variant association methods can control for potential confounders,
difficulties arise if one or some of the covariates are partially missing on some individuals.
Missing covariate information can arise through a range of processes including issues with
the data collection process or due to design considerations, e.g. when a variable is measured
on only a subset of individuals due to cost. Currently, a common approach for dealing
with missing covariate information in rare variant studies is complete case analysis through
case deletion, in which individuals with missing covariates are dropped from the analysis.
Unfortunately, such approaches are problematic. In particular, using complete case observations
only for partially missing covariates results in loss of power due to reduction in sample size.
This is particularly troublesome for studies of rare variants if the subject with missing
covariate information also is one of the few indviduals who have the particular variant.
Furthermore, if the data are missing at random (MAR), such that missingness depends on
the observed covariates, and only complete observations are used in the analysis, then there
is a great danger of biased parameter estimation and potential difficulties in controlling type
I error (Little and Rubin, 1987; Knol et al., 2010).
Recognizing the potential for misleading results or reduced power due to missing covariate
information, in this paper, we consider the problem of partially missing covariates within the
context of genetic sequencing studies of rare variants and develop an approach for testing the
effect of rare genetic variants on a quantitative trait in the pressence of covariates that are
MAR. Specifically, we focus attention on the popular sequence kernel association test (SKAT)
(Wu et al., 2011), a region based test of rare variant effects in which pair-wise similarity in
trait value between study subjects is compared to pair-wise similarity in rare variant profiles,
with correlation suggestive of association. We extend SKAT accommodate missing data via
use of a standard maximum likelihood based strategy for missing data based on the approach
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of Ibrahim (1990). In particular, maximization of the likelihood can proceed via iteratively re-
weighted least squares (IRLS) such that we can use the weighted linear model at convergence
and apply those weights to SKAT.
Our objectives for gene sequence association study when covariates are partially missing
and MAR are threefold: First, we would like to estimate the effects of covariates without bias
and with high efficiency (low variance estimator). Second we would like to conserve SKAT
type I error. Finally we are interested in maximizing SKAT power. Results of our simulation
studies we show that complete case fails to estimate the effects of covariates unbiasedly and
loses power as the proportion of missingess increases. In comparison, maximum likelihood
acheives unbiased estimation of the effects of covariates, controls type I error, and retains
power in comparison to oracle. Power is particularly improved in scenarios where the missingness
proportion is large.
Our work restricts attention to the scenario in which only covariates may be partially
missing at random. We do not consider the case in which variant information is missing
— standard imputation techniques can accurately impute genotypes or at least dosages.
Furthermore, we restrict attention to the MAR case and do not consider the case of not
missing at random (NMAR) as general solutions for accommodating NMAR data remain
elusive and require examination on a study-by-study basis. We also note that although our
work focuses on SKAT, due to the close relationship between SKAT and other method such
as burden tests or the C-alpha method, our approach can be seamlessly used for other testing
procedures as well.
The remainder of this chapter is organized as follows. In the next section, we review the
general SKAT method and then review the likelihood based approach for accommodating
missing covariate information. We then describe how one can adapt SKAT to accommodate
missing covariates. We examine the type I error rate and power of our approach, in comparison
to complete case analysis, through a series of computer simulations. We conclude with a brief
discussion.
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4.2 Methods
For simplicity, we describe our work within the context of testing the association between
the rare variants within a single region on a quantitative (continuous) trait, with the understanding
that the approach can be applied genome-wide with appropriate adjustment for multiple
comparisons. We denote the quantitative outcome for the ith individual in the study as yi
(i = 1, . . . , n). The p variants within the region are in Zi = [Zi1, Zi2, . . . , Zip]
′ and the vector
of covariates are denoted by Xi. The objective is test for the effect of Zi on yi while adjusting
for Xi with the additional complexity that variables within Xi may be missing for some
individuals.
Here, we first describe the SKAT method for association testing in the scenario in which
there is no missingness in X and then describe the likelihood based framework we are operating
under. We then present our proposed extension of SKAT that accommodates missingness,
focusing on the scenario in which only a single dichotomous covariate has missingness.
4.2.1 SKAT
SKAT is a similarity based test that operates by comparing pair-wise genotypic similarity
between individuals to pair-wise phenotypic similarity, with correlation suggestive of association.
To relate the variants and the covariates to the outcome, SKAT uses the semiparametric model
yi = β0 + X
′
iβ + h(Zi) + εi
where β0 is an intercept, β is a vector of regression coefficients for the covariates, and εi is
an error term with mean zero and variance σ2. Within the kernel machine framework, the
variants of interest Zi for the i-th individual are related to the outcome only through the
function h(·) which is a general function lying in a functional space generated by a positive
definite kernel function K(·, ·). Intuitively, K(Zi,Zi′) measures similarity between i-th and
i′-th individuals in the study based on Z, the variants of interest.
The function h(·) fully specifies the relationship between the variants and the outcome:
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if one sets K(Zi,Zi′) = Z
′
iZi′ , which is the linear kernel, then this implies that the function
h(Zi) =
∑p
j=1 αjZij for some coefficients αj , i.e. h(·) is linear and the outcome depends on the
variants in a linear manner. By specifying a different kernel, one may specify an alternative
model.
Under the default SKAT parameters, K(Zi,Zi′) =
∑p
j=1 θjZijZi′j where θj is equal to a
the beta probability density function with parameters 1 and 25 evaluated at the MAF for
the j-th variant. This corresponds to a linear model but with additional up-weighting for the
effect of rarer variants.
To test the effect of the rare variants under SKAT corresponds to testing H0 : h(Z) = 0.
This can be done by exploiting the connection between kernel machine methods and linear
mixed models. In particular, defining the kernel matrix, K, to be the n-by-n matrix with
i, i′-th term equal to K(Zi,Zi′), we can treat h(Z) as a vector of subject specific random
effects with mean 0 and variance τK. Then whether h(Z) = 0 corresponds exactly to testing
whether τ = 0. This is done by construction of the variance component score statistic
Q =
(y − ŷ)′K(y − ŷ)
σ̂2
where ŷ = β̂0 + Xβ̂ with β̂0, β̂, and σ̂ estimated under H0.
To obtain a p-value for significance, asymptotically under the null, Q ∼∑λjχ21 which is
a mixture of chi-squares distributions, with weights λj equal to the eigenvalues of P
1/2
0 KP
1/2
0
where P0 = I−X(X′X)−1X′. This null distribution can be easily approximated using moment
matching approaches or exact methods allowing for rapid p-value computation.
SKAT has been successfully applied in many studies, but unfortunately, it cannot accommodate
missing covariates. Further developments are necessary.
4.2.2 Regression with Partially Missing Covariates
In many genetic association studies, including studies of rare variants, study subjects with
missing covariate information are simply omitted from the analysis through complete case
(CC) analysis which restricts analysis to a smaller subset of individuals on which complete
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covariate information is observed. Although CC analysis is operationally simple, and in
some studies the proportion and mechanisms of missingness do not dramatically influence the
results, CC has the disadvantage of lower power due to reduced sample size (Little and Rubin,
1987). It is also biased under MAR scenarios and has decreased power compared to full-data
methods (Knol et al., 2010). Thus, we consider the use of a full maximum likelihood based
approach which is fitted via iteratively re-weighted least squares (IRLS). We will compare
both CC analysis and our proposed strategy to an oracle procedure, that is an idealized
scenario where the missing covariates are known.
As earlier, we again assume that the quantitative outcome for each individual is given as
yi and Xi are the covariates. However, without loss of generality and for ease of notation
in our exposition, we assume that there are only two covariates Xi1 and Xi2 and that Xi2
is a dichotomous variable that may be missing in some individuals but that Xi1 is observed
for all i = 1, . . . , n subjects. We further let Ri be an indicator for whether or not Xi2 is
observed for the ith subjects (Ri = 1 if Xi2 is observed). We will later describe extensions and
accommodation of multiple missing covariates and continuous covariates. As noted previously,
we assume that Zi is observed without missingness.
Under the null model, in which the variants do not influence the outcome, we have
yi = β0 + β1Xi1 + β2Xi2 + εi
where εi is again a normal error term with mean zero and variance σ
2. Furthermore, we
assume that
logitP (Xi2 = 1) = logitµi = α0 +Xi2α
for some coefficients α0 and α and the indicator of missingness is related to the outcome and
the covariates through the logistic model
logitP (Ri = 1) = logitηi = ω0 +Xi1ω1 + yiωy
for some coefficients ω0 and ω1 and ωy. This way X2 is MAR since R|y,X1 is independent
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of X2. Under this model, we can then use maximum likelihood to accommodate the missing
covariates without omission of samples.
Full-data Maximum likelihood
Maximum likelihood (ML) can be used to avoid the problem of discarding data which leads
to reduced power and possible bias. Here, a distribution is given to the missing data and the
resulting likelihood is integrated across all possible values of the missing covariate. When Xi2
is observed, the full likelihood can be written as a product of conditional likelihoods.
p(yi, Xi2, Ri|Xi1, β, α, ω) = p(yi|Xi1, Xi2, β)p(Xi2|Xi1, α)p(Ri|yi, Xi1, ω)
If Xi2 is continuous, the probability must be integrated across all possible values of the missing
Xi2. The probability for R can be evaluated outside the integral when the missingness occurs
at random.
p(yi, Ri|Xi1, β, α, ω) = p(Ri|yi, xi1, ω)
∫
xi
p(yi|Xi1, Xi2, β)fXi2(xi|Xi1, α)dxi
If Xi2 is discrete, the probability must be summed across all possible values of the missing
Xi2. Again, the probability for R can be evaluated outside the integral when missingness
occurs at random.
p(yi, Ri|Xi1, β, α, ω) = p(Ri|yi, Xi1, ω)
∑
xi
p(yi|Xi1, Xi2, β)p(Xi2 = xi|Xi1, α)
In summary, the full-data log-likelihood is:
n∑
i=1
Ri log [p(yi, Xi2, Ri|Xi1, β, α, ω)] + (1−Ri) log [p(yi, Ri|Xi1, β, α, ω)]
which can be solved throught either the Newton-Raphson method or by the Expectation-
Maximization (EM) algorithm.
ML leads to unbiased results under MAR if the model is correctly specified. This is a clear
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Y X1 X2 R
y1 X11 X12 1
y2 X21 X22 1
y3 X31 N/A 0
y4 X41 X42 1
y5 X51 N/A 0
...
...
...
...
yn Xn1 Xn2 1
−→
Y X1 X2 w
y1 X11 X12 1
y2 X21 X22 1
y3 X31 0 pi0
y3 X31 1 pi1
y4 X41 X42 1
y5 X51 0 pi0
y5 X51 1 pi1
...
...
...
...
yn Xn1 Xn2 1
Figure 4.1: Data augmentation using the approach of Ibrahim (1990) involves expanding each
observation with missingness based on values that the missing variable can take. Here we
assume that X2 is dichotomous.
advantage over complete case and over most cases of imputation. An additional advantage
of ML over imputation is that ML produces the same result each time, while most cases of
imputation lead to differing results because of the variability of the imputed data.
Full-data maximum likelihood by Iteratively Reweighted Least Squares
Ibrahim (1990) proposed a weighted maximum likelihood to solve the above maximum
likelihood. This is very helpful when the above likelihood does not lend itself to a closed form.
Under Ibrahim’s method, missing observation are expanded to multiple pseudo-observed
observations and weighted according to their posterior probability of being observed (Fig.
4.1).
Following Ibrahim, the expressions take the form of a weighted complete data log-likelihood
based on N =
∑n
i=1 ki observations, where ki is the number of distinct covariate patterns for
observation i. Thus, iteratively reweighted least squares (IRLS) is used in conjuction with the
Newton Raphson algorithm to solve for covariate effects (β) and parameters of the distribution
of missing covariate (α). This Newton-Raphson algorithm is considerably more convenient
than the previous because it lacks the sum or integral.
The algorithm described by Ibrahim is as follows:
1. Augment missing data to weighted pseudo-observed data as described above. Each
missing observation is augmented so that each possible realization of X2 is represented
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by one psuedo-observation. Those pseudo-observations are weighted (w) according the
thier posterior probability of being observed.
where pi0 = 1− pi1 = P (Xi2 = 0|yi, Xi1); and generally for missing Xi2:
wi = P (Xi2|yi, Xi1) = p(yi|Xi1, Xi2,β, σ
2)p(Xi2|Xi1,α)∑
Xi2
p(yi|Xi1, Xi2,β, σ2)p(Xi2|Xi1,α)
while wi = 1 for non-missing Xi2
2. Use Newton Raphson on augmented psuedo-complete data, using complete case estimates
as starting estimates. This form of Newton-Raphson with a pseudo full-likelihood
provide tractible iterations in comparison with the difficult iterations involved with
missing data. There are no sums or integrals to differentiate.
 β(t+1)
σ2(t+1)
 =
 β(t)
σ2(t)
+
 ∑XTi wiXi
∑
XTi wi(yi−Xiβ)
σ2∑
XTi wi(yi−Xiβ)
σ2
−∑wi
2σ2
+
∑
wi(yi−Xiβ)2
(σ2)2

−1  ∑XTi wi(yi −Xiβ)
−
∑
wi
2 +
∑
wi(yi−Xiβ)2
2(σ2)

α(t+1) = α(t) +
[∑
XTi wiXiµi(1− µi)
]−1∑
XTi wi(Xi2 − µi)
3. Update w. With each subsequent iteration, the posterior probability of observating a
psuedo-observation converges toward a more probable full-information estimate. The
initial posterior probability is based on complete case only, which is biased assuming
MAR.
w
(t+1)
i =
p(yi|Xi1, Xi2, β(t+1), σ2,(t+1))p(Xi2|Xi1, α(t+1))∑
Xi2
p(yi|Xi1, Xi2, β(t+1), σ2,(t+1))p(Xi2|Xi1, α(t+1))
4. Repeat 2 and 3 until convergence. Under MAR, the estimates at convergence are
unbiased.
The objective then is to adapt this approach within the context of SKAT in order to
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accommodate missing covariates for rare variant association testing. Since the likelihood is
fit using a sequence of weighted linear regressions, the idea will be to use augment the data
(including rare variants) and then using the working linear model at convergence and we
apply the weights to SKAT and assess the significance of the rare variants.
4.2.3 Accommodating Missing Covariate Information in Tests of Rare Variants
The objective of our work is to allow for inclusion of subjects with partially missing
covariates in studies of rare variants, in contrast to current strategies which focus on complete
case analysis. To do this, we will employ the maximum likelihood approach implemented via
the IRLS approach of Ibrahim (1990) within the context of rare variant analysis. We do
this primarily within the context of SKAT, but we also discuss extensions to alternative rare
variant testing procedures.
SKAT with Missing Covariates
Original development of the kernel machine testing framework using mixed models, the
overaraching framework for SKAT, was done within the context of quantitative outcomes.
Analysis of dichotomous and other types of outcome variables was done by using likelihood
based models which can be fit via a sequence of weighted linear models, IRLS. Testing for non-
quantitative outcomes then proceeds by utilization of the working linear model at convergence.
Since we are proposing to use a full likelihood based approach for accommodation of missing
covariates which can be fitted using IRLS, we also see that, at convergence, the working model
is essentially just a weighted least squares regression. Thus, SKAT can also be applied using
this working linear model.
Using the augmented versions of y, X and Z containingN instead of n observations, we can
again generate a kernel matrix K with (i, i′)-th element equal to K(Zi,Zi′) =
∑p
j=1 θjZijZi′j
where θj is as defined earlier and Z now denotes the augmented matrix of genotype values.
Then K is now N × N since it is generated from the augmented Z. Using the augmented
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data, we can construct a SKAT score statistic
Qw =
(y −Xβˆ)TWKW(y −Xβˆ)
σˆ2w
where β̂ is estimated under the null model which is fit via IRLS and W = diag(wi). The
estimate for σ2 is given by
σˆ2w =
1
n− p
n∑
i=1
 ∑
Xi2=0,1
(wi|Xi2)(yi −Xiβ)
2 .
Overall, Qw is similar in form to the original SKAT score statistic except the augmented
observations are weighted by their contribution to the model based on the probability of the
missing value.
To obtain a p-value for significance, asymptotically, Qw is a mixture of chi-squares distributions,
with weights λjw equal to the eigenvalues of P
1/2
0WKP
1/2
0W ; where P0W = W−WX(X′WX)−1X′W
for quantitative traits. Again, this can be approximated using moment matching approaches
(Satterthwaite, 1946; Liu et al., 2009) or exact methods (Davies, 1980).
As noted, the idea behind our approach is that we are simply using the weighted linear
model at convergence from maximization of the likelihood function for accommodating missing
covariates. More intuitively, the original SKAT statistic essentially boils down to a quadratic
form of the residuals estimated under the null model. Missing covariates prevent estimation
of the null residuals, consequently we are simply obtaining unbiased estimates of the results
using a likelihood based approach and then plugging these into the SKAT score statistic with
accommodation for the correlation between residuals and for the weighted augmentation.
Othere Rare Variant Testing Approaches with Missing Covariates
Although the emphasis of our work is on using SKAT for rare variant testing, our framework
can also be easily applied to other rare variant tests. In particular, we have noted in the
previous Chapter that many other tests are equivalent to SKAT using particular kernels. For
example, the count based collapsing method for testing rare variants corresponds to SKAT
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using the kernel function
K(Zi,Zi′) =
 p∑
j=1
Zij
 p∑
j=1
Zi′j

were the Z are again assumed to have been augmented. Then to allow for missing covariates
under the count based collapsing method, we need only replace the usual SKAT kernel matrix
in Qw with a kernel matrix constructed based on the collapsing method. To use a different
test which is equivalent to SKAT under a particular kernel, we need only change the kernel
matrix.
4.2.4 Continuous Missing Covariates and Multiple Missing Covariates
For simplicity, we have presented our method under a simple scenario in which we have
only two covariates of which one is completely observed and the other is partially missing.
If we have multiple covariates which are completely observed, then the earlier results hold
except we simply treat Xi1 as a vector. However, we have further assumed that the missing
covariate is dichotomous and that only one of the covariates is partially missing. In this
section we discuss how we can relax these assumptions. We emphasize that this only reflects
the estimation under the null model and thus the overall rare variant testing procedure remains
the same except that we need to use an alternative approach to estimate the weights for the
observations with missing covariates and then everything else remains as earlier.
When the missing covariate is continuous, we can still use the same approach as earlier
except that f(Xi2|Xi1) is approximated by a discrete distribution and monte carlo is used
to select L distinct points from the distribution along with the corresponding probability
Ibrahim et al. (2004). Weights are then generated similar to the dichotomous case, and the
weighted complete data log-likelihood is evaluated in the same way as before with
wi = P (Xi2|yi, Xi1) =
p(yi|Xi1, Xi2, β, σ2y)f(Xi2|Xi1, α, σ2x)∫
p(yi|Xi1, Xi2, β, σ2y)f(Xi2|Xi1, α, σ2x)dXi2
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 α(t+1)
σ
2(t+1)
x
 =
 α(t)
σ
2(t)
x
+
 ∑XTi1wiXi1
∑
XTi1wi(Xi2−Xi1α)
σ2x∑
XTi1wi(Xi2−Xi1α)
σ2x
−∑wi
2σ2x
+
∑
wi(Xi2−Xi1α)2
(σ2x)
2

−1  ∑XTi1wi(Xi2 −Xi1α)
−
∑
wi
2 +
∑
wi(Xi2−Xi1α)2
2(σ2x)
 .
These values can be plugged in to obtain the SKAT score statistic again and a corresponding
p-value.
The approach can also be easily extended to the scenario in which there are multiple
missing covariates. For example, suppose that there are three covariates X1, X2 and X3 and
that X2 and X3 are missing for some individuals in the study. Under our assumptions, we
can extend the likelihood such that the distribution of X3 is conditional upon X1 and X2. In
particular, we use the null model
y1 = β0 + β1Xi1 + β2Xi2 + β3Xi3 + εi
where all variables are as before except that we have an additional covariate Xi3 which is
missing in some individuals. Then we assume that
X2|X1, α ∼ Ber
(
µ =
eXα
1 + eXα
)
; r2|y, x1, ω ∼ Ber
(
η =
eXω
1 + eXω
)
x3|x1, x2, δ ∼ Ber
(
µ =
eXδ
1 + eXδ
)
; r3|y, x1, x2, γ ∼ Ber
(
η =
eXγ
1 + eXγ
)
.
Weights are then generated in the same way as before using the likelihood with the additional
covariates and correspond to the posterior probability of being observed at a particular value.
wi = P (Xi2, Xi3|yi, Xi1) = p(yi|Xi1, Xi2, Xi3, β, σ
2)p(Xi2|Xi1, α)p(Xi3|Xi1, X2i, δ)∑
Xi2
p(yi|Xi1, Xi2, Xi3, β, σ2)p(Xi2|Xi1, α)p(Xi3|Xi1, Xi2, δ) .
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4.3 Results
4.3.1 Type I Error Simulations
We conducted a series of simulations to assess the type I error of our method as compared
to complete case analysis using scenarios similar to those of Wu et al. (2011). Specifically, we
simulated a population of 10,000 haplotypes on a region of approximately 5 kb long containing
100 genetic variants using a coalescent model (Schaffner et al., 2005) with parameters set to
mimic real genetic data from a population of European ancestry.
To generate a single simulated data set, we then randomly selected and paired haplotypes
to generate genetic information on n diploid individuals. For each individual, we simulated
two covariates with X1 ∼ N(0, 1) and X2 ∼ Ber(µi) with µi = 0.5Xi1. Then the outcome for
each individual was generated as
yi = 1 + 0.5Xi1 + 0.5Xi2 + εi
where εi ∼ N(0, 1). Note that the outcome does not depend on Z. Each Xi2 was set to be
missing with probability ηi, where
logitηi = ω0 + ω1yi + ω2Xi1
with ω tuned to achieve a particular degree of total missingness.
We considered scenarios in whichX2 was missing in 5%, 15%, 30% or 60% of the individuals.
We also allowed n to vary as 500, 1000, and 2500. For each percentage of missingness in X2
and sample size, we simulated 1000 data sets. We applied SKAT using complete case analysis
and SKAT using IRLS to each simulated data set. We also considered applying SKAT under
the oracle: that is we applied SKAT assuming that we knew the true value of X2. While this
is impossible in practice, it provides a reference to which we can compare our results. For
each method, the type I error was estimated as the proportion of p-values less than 0.05.
The estimated type I error results are given in Table 4.1. Overall, each method controls
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Percent Missing
Method n 60% 30% 15% 5%
CC 500 0.042 0.050 0.031 0.051
1000 0.040 0.050 0.056 0.049
2500 0.054 0.054 0.055 0.043
Oracle 500 0.046 0.046 0.046 0.046
1000 0.040 0.040 0.040 0.040
2500 0.053 0.053 0.053 0.053
IRLS 500 0.047 0.045 0.045 0.048
1000 0.039 0.040 0.042 0.037
2500 0.052 0.055 0.050 0.057
Table 4.1: Type I error simulation results at the α = 0.05 level comparing SKAT using
complete case (CC), SKAT with IRLS to accommodating missing values (IRLS), or SKAT
assuming that the missing values are known (Oracle).
the type I error rate. We also found that the coefficients for the covariates were estimated
with no bias under the oracle and maximum likelihood based methods (not shown), though
this was not the case for the complete case analysis. That the type I error rate is nearly
controlled for the complete case approach is surprising, given the bias, but may be due to the
fact that the SKAT method tends to be conservative in many cases.
4.3.2 Power Simulations
We also examined the power of the proposed approach in comparison to the oracle
procedure and to complete case analysis.
Using the same strategy as before, we simulated genotype information and covariates
in the same manner as in the type I error simulations. However, since we then simulated
outcomes under the alternative model in which the rare variants within the region influence
the outcome. Specifically, we simulated the outcome yi as
yi == 1 + 0.5Xi1 + 0.5Xi2 + β
cZciεi
where Zci denotes the genotypes of the causal variants and β
c are the regression coefficients
for the causal variants. Here, the causal variants were randomly selected as 5% of the variants
with true MAF < 3%. The effect for the jth causal variant was given as βcj0.4| log1 0qj |, where
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Figure 4.2: Power simulation results comparing SKAT using complete case (CC), SKAT with
IRLS to accommodating missing values (IRLS), or SKAT assuming that the missing values
are known (Oracle).
qj is the true MAF of the j
th causal variant. This allows rarer variants to have strong effects
on the outcome. Other parameters within the model are as before: we again considered n =
500, 1000, and 2500 and missingness percentages for X2 of 5%, 15%, 30% or 60%, and for each
sample size and proportion of missingness, we again simulated 1000 data sets. We applied the
SKAT under complete case, under the oracle, and under our proposed IRLS based approach
to each data set and estimated the power in each scenario as the proportion of p-values less
than the stringent α = 10−6 which reflects a level on the order of genome-wide significance.
The power results are shown in Figure 4.2. Results show that total power increases
for all methods as sample size increases. However, for fixed sample size, as the proportion of
missingness increases, complete case analysis loses power due to reduction in sample size (60%
missingness when n = 1000 leads to power that is comparable to no missingness and with
n = 500). On the otherhand, the proposed application of SKAT under the IRLS framework
to accommodate missingness maintains power that is close to the oracle procedure, even
when the missingness proportion is high. Interestingly, when the proportion of missingness
is modest, e.g. 5%, the loss in power is not large for complete case analysis, suggesting that
under some scenarios complete case analysis may not be terrible. Though, as the proportion
of missingness goes up, the relative performance is much worse.
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4.4 Discussion
Controlling for potential confounders and the effects of demographic and environmental
covariates is important for sequencing association studies of rare variants in order to prevent
spurious associations and can also improve power through reduction of the standard error.
However, missing covariate data sometimes occurs and little has been done to accommodate
the missing covariates. We have proposed a strategy based on full maximum likelihood using
IRLS that can accommodate rare variants within the context of SKAT. We show through
simulations that the approach conserves type I error while maintaining power close to the
oracle. In contrast, complete case analysis, a standard approach for treatment of partially
missing covariates, results in reduced power as the proportion of missingness gets large. These
properties support the use of IRLS when SKAT is to be used in the presence of partially
missing covarates.
Our proposed strategy shares many of the advantages of SKAT based tests. In particular,
as a score test, the null model, which is where all adjustments for missingness are made, needs
to be fit only once. This reduces the computational expense in genome wide experiments.
Similarly, a p-value can be directly estimated without the need for monte carlo methods.
However, since SKAT is closely related to several different methods, the proposed approach
can also be directly applied to conduct several other tests including the CAST method, the
count based collapsing method, and the C-alpha test, by simply switching the kernel function
used to measure similarity between subjects based on their rare variants. Using IRLS and
maximum likelihood to accommodate rare variants with still preserve the properties of each
of these tests such that collapsing approaches will still be more powerful when the majority
of variants function unidirectionally and SKAT and C-alpha will still be more powerful when
the variants function bi-directionally. The approach can also be easily used within the context
of other tests which are not exactly equivalent to SKAT under a single kernel, such as the
variable threshold test (Price et al., 2010) and SKAT-O (Lee et al., 2012).
In our current work, we have focused on scenarios where there is only a single dichotomous
covariate with considerable missingness. We have discussed the inclusion of continuous
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covariates and multiple missing covariates, but all of this is within the context of quantitative
outcomes. The approach can, in principle, be applied within the context of dichotomous (i.e.
case-control) outcomes, but further development is needed. Another area requiring further
research is inclusion of missing data within the variants; we find that this is, generally,
less problematic since current imputation techniques are comparable to likelihood based
procedures for common variants, but whether this still holds for rare variants is unclear
and warrants more research.
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Chapter 5
Kernel Machine Testing using Maximum Likelihood by IRLS for Gene Level
Analysis of Methylation Data with Missing Covariates
5.1 Introduction
Large scale epigenome wide association studies (EWAS) Rakyan et al. (2011), in which the
DNA methylation at hundreds of thousands of CpGs along the genome can be simultaneously
measured across a large number of samples Bibikova et al. (2011); Sandoval et al. (2011), have
resulted in the identification of differentially methylated CpGs associated with differences with
a range of outcomes and contions Joubert et al. (2012); Shen et al. (2013); Heyn et al. (2013,
2012). These discoveries can provide a breadth of information from fundamental insights
into the mechanisms underlying complex disease and to potential biomarkers for diagnosis or
prognosis Laird et al. (2003); Attar (2012). However, despite the successes, analysis of EWAS
remains challenging Bock (2012).
Standard analysis of EWAS proceeds via individual CpG analysis wherein the association
between each CpG and an outcome variable (e.g. disease state, environmental exposure,
etc.) is assessed one-by-one, followed by adjustment for multiple comparisons. Any CpGs
surviving this correction are called differentially methylated and followed for validation and
interpretation. However, this approach suffers a number of limitations (Subramanian et al.,
2005; Wu and Lin, 2009). First, the need to correct for large number of multiple corrections
can lead to low power such that nothing meets the criteria for signifiance. Alternatively, too
many features are called significant leading to difficulties in interpretation. Individual feature
analysis also fails to allow for capture of multi-feature or interactive effects. More generally,
such approaches have been found to yield poor reproducibility. An alternative to individual
CpG analysis is to use multi-CpG analysis in which we group multiple CpGs together, such as
those lying within a gene region, and test their cumulative effect on the outcome. Following
similar principles as in gene expression and genetic association studies (Subramanian et al.,
2005; Goeman et al., 2005; Wessel and Schork, 2006; Liu et al., 2007b, 2008; Tzeng and
Zhang, 2007; Wang et al., 2007, 2010; Schaid et al., 2011), multi-CpG analysis can be used
to overcome many of the limitations surrounding individual CpG analysis.
A particular approach that can be used for multi-CpG analysis is the kernel machine
regression test which was initially proposed for gene expression data (Liu et al., 2007b, 2008)
but has been also extended to analysis of SNPs (Kwee et al., 2008; Wu et al., 2010) and
rare variants (Wu et al., 2011). Briefly, the approach is built upon a semi-parametric model
within the kernel machine framework (Cristianini and Shawe-Taylor, 2000) in which the effects
of a group of features of interest (e.g. genes in a pathway, SNPs in a region, etc.) are
modeled nonparametrically and while some simple confounding covariates are adjusted for
parametrically. A score test is used to test for an association between the outcome and the
nonparametrically modeled group of features while linearly adjusting for the covariates. A
key advantage of the kernel machine framework is the non-parametric modeling of the multi-
feature effects. The approach can be directly applied to EWAS data in which the CpGs are
grouped at the gene level.
An example of a study in which kernel machine regression based multi-CpG testing is
useful is a recently conducted study of child birth weight in which epigenetic profiling of
cord blood from approximately 1000 new-born infants was conducted within the Norwegian
Mother and Child Birth Cohort (MoBa). In addition to methylation measurements at
485,000 CpG sites within 20,000 genes, for each subject in the study, a wide range of
potential confounders including demographic variables and maternal behavior, diet, and
environmental exposure data during pregnancy were collected. The goal was to identify
associations between methylation at the gene level and birth weight while adjusting for the
confounding variables. One particular confounder of interest is maternal vitamin D exposure
which has been hypothesized to be linked to a range of birth outcomes and is a potential
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confounder for birth weight. Unfortunately, vitamin D was measured in only a subset of the
individuals such that the value is missing for a substantial number of subjects. Since each
of the genes contains multiple CpG sites and the outcome is continuous, least square kernel
machine regression is a natural analytic strategy, but the inability of kernel machine methods
(as well as other multi-CpG tests) to accommodate partially missing covariate information
poses a significant challenge.
To overcome the difficulties associated with gene level analysis of the MoBa epigenetic
study of birth weight, we will consider using the method developed within the previous
chapter. Although the development of the work was within the context of rare variant
analysis, the overarching framework is generic and can also be applied in the present setting
where we are interested in testing the effect of multiple CpGs instead of multiple rare variants.
Despite this, there are a number of important differences between methylation values and rare
variants. For example, methylation is typically measured as a continuous percentage (which
is often logit transformed to be approximately normal), the number of CpGs within a gene is
typically modest, and the correlation between adjacent CpGs is higher (whereas rare variants
have low correlation due to their rarity). Therefore, this chapter involves investigation of the
utility of the previous work on kernel machine testing with missing covariate information for
gene level analysis of DNA methylation data.
The remainder of the chapter is organized as follows. Since the methods have been
presented within the previous chapter, we do not repeat that here. Instead, in the next
section, we directly proceed with simulation studies to examine the use of kernel machine test
with missing covariates within the context of DNA methylation analysis. Specifically, we will
compare the use of complete case analysis with the proposed method in terms of controling
type I error and power. We then apply the proposed method to the motivating MoBa study
of birth weight. We conclude with a very brief discussion.
5.2 Simulations
Since the structure of DNA methylation data is inherently different from rare variant data,
we conducted simulations to ensure that the approach is also valid for continuous predictors
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(the CpGs within a gene) and to examine the empirical power of our approach in comparison
to the simpler complete case analysis strategy. We compare both complete case analysis and
our proposed approach to the oracle procedure, i.e. kernel machine testing with the covariate
value treated as known.
For our simulations, we let yi be a continuous outcome for the i
th subject in the study
(i = 1, . . . , n) and is simulated as
yi = −3 + 0.5Xi1 − 0.5Xi2 + Z′iξ + εi
where Zi is the vector of CpG methylation values within the gene with corresponding coefficients
ξ and εi ∼ N(0, 1). Here, we let covariate Xi1 follow a standard normal and covariate Xi2
follow a normal distribution with mean equal to 0.5Xi1 and variance σ
2
x. Since our interest is
in examining missingness in the covariates, we allow Xi2 to be missing for some individuals
— for simplicity we assume that missingness is restricted to Xi2. We let ri be the indicator of
whether Xi2 is observed and we assume that the probability that Xi2 is observed (i.e. ri = 1)
depends on yi and Xi1 such that we have
logitP (ri = 1) = η = ω0 + ωXi1
Thus, Xi2 is considered to be missing at random (MAR) since ri|yi, Xi1 is independent of
Xi2.
5.2.1 Type I Error
We first test type I error by applying SKAT to simulated data sets where methylation
within the gene (Z) has no effect on the outcome, i.e. ξ = 0.
For each individual, we simulated methylation data as a vector of 30, possibly correlated,
normal random variables: Zi ∼MVN(0,Σ). Although methylation is measured as a proportion
between 0 and 1, it is often logit transformed to approximate normality. We considered
five different correlation structures for the methylation values: independence, compound
symmetry with ρ = 0.15, autoregressive with ρ = 0.9, block autoregressive with 10 blocks
67
with ρ = 0.9 within each block, and block compound symmetry with 10 blocks and ρ = 0.15
within each block. We tuned ω such that percent of missing covariate X2 was 5%, 15%, 30%
or 60%. We also considered sample sizes of n = 500 and n = 1000.
For each choice of correlation structure, sample size, and percent missingness, we simulated
10,000 data sets. For each data set, we conducted a complete case analysis using kernel
machine testing under a linear kernel to assess the cumulative effects of the simulated CpGs
on the outcome. We also applied the proposed kernel machine method with accommodating
for missing covariates to each data set and for comparison, we also considered the oracle
procedure in which we pretend that we knew the missing value. The type I error rate for
each method was the proportion of p-values less than α level, where we considered several
diffferent possible levels.
Table 5.1 shows type I error for the case of independent methylation data. Type I
error was conserved for all 3 methods. However Figure 5.1 shows that type I error is not
conserved for complete case analysis under certain correlation structures in methylation data.
Specifically, type I error is well beyond acceptable limits when methylation is correlated
in an autoregressive or compound symmetric fashion. Type I error inflation increases as
missingness increases. Interestingly, under a block correlation structure improves type I error,
but complete case still exceed limits in some cases. Type I error is conserved by using the
oracle procedure or by using maximum likelihood by IRLS for all methylation correlation
structures and sample sizes, even at more modest α levels. These results are different from
what we observed with regard to rare variant analysis where type I error appeared to be
conserved for complete case analysis, but this may be due to the fact that rare variants have
near spherical correlation due to their low allele frequencies.
5.2.2 Power Simulations
We further assessed the power of the proposed kernel machine test using ML with IRLS
to accommodate missing covariates. We also compared the usage of complete case analysis
and the oracle procedure. As in the type I error simulations, we considered the same
correlation structures and sample sizes. We also simulated covariates as in the type I error
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n=500
%mis 5% 5% 5% 15% 15% 15%
α level: 0.0500 0.0050 0.0005 0.0500 0.0050 0.0005
cc 0.0442 0.0030 0.0002 0.0434 0.0035 0.0005
oracle 0.0447 0.0028 0.0004 0.0447 0.0028 0.0004
irls 0.0444 0.0027 0.0004 0.0443 0.0030 0.0003
%mis 30% 30% 30% 60% 60% 60%
α level 0.0500 0.0050 0.0005 0.0500 0.0050 0.0005
cc 0.0426 0.0031 0.0003 0.0422 0.0029 0.0002
oracle 0.0447 0.0028 0.0004 0.0447 0.0028 0.0004
irls 0.0441 0.0031 0.0004 0.0412 0.0030 0.0002
n=1000
%mis 5% 5% 5% 15% 15% 15%
α level 0.0500 0.0050 0.0005 0.0500 0.0050 0.0005
cc 0.0464 0.0046 0.0002 0.0539 0.0044 0.0004
oracle 0.0467 0.0045 0.0004 0.0467 0.0045 0.0004
irls 0.0475 0.0041 0.0004 0.0478 0.0042 0.0004
%mis 30% 30% 30% 60% 60% 60%
alpha 0.0500 0.0050 0.0005 0.0500 0.0050 0.0005
cc 0.0538 0.0055 0.0005 0.0559 0.0054 0.0006
oracle 0.0467 0.0045 0.0004 0.0467 0.0045 0.0004
irls 0.0460 0.0046 0.0003 0.0473 0.0044 0.0004
Table 5.1: Estimates of type I error in the application of kernel machine testing with complete
case (cc) treatment of missing data, with oracle knowledge of the missing covariate values,
and with ML by IRLS based analysis. Estimates are based on 10,000 simulated null model
data sets under different sample sizes (n), signifiance levels (α), and percentage missingness
(%mis). CpGs are uncorrelated here.
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Figure 5.1: Scaled estimates of type I error in the application of kernel machine testing with
complete case (cc) treatment of missing data, with oracle knowledge of the missing covariate
values, and with ML by IRLS based analysis. Horizontal line indexes the ideal type I error
level (alpha) and scaled to 100. Estimates are based on 10,000 simulated null model data sets
under different signifiance levels, percentage missingness, and correlation structures. Sample
size is fixed at n = 500.
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simulations including missingness patterns, but now we allow the outcome yi to depend
on the methylation markers Z. In particular, we randomly selected a single CpG to be
causal with effect size ξ which differed depending the correlation structure: ξ = 0.045 when
we used an independent or block compound symmetric correlation structure, ξ = 0.025
when we used a block autoregressive structure, and ξ = 0.015 when we used a compound
symmetric or autoregressive structure. Power was estimated based on 10,000 simulations for
each correlation structure and missingness pattern.
Power results are presented in Figure 5.2 and show that power of complete case decreases
substantially as percent missingness increases, falling to zero as missingness approaches 60%.
On the contrary, oracle and using kernel machine testing using ML with IRLS to accommodate
missingness exhibit power that is very similar throughout levels of missingness. Using ML with
IRLS does exhibit a modest decrease in power compared to oracle but this is considerably
better than complete case analysis, despite the fact that complete case analysis does not
well control type I error under some scenarios. These results are generally consistent across
the different correlation structures in methylation data. Qualitatively similar results were
observed for n = 500 and are not presented.
5.3 Application to Epigenetic Study of Birth Weight
We applied the kernel machine testing approach with ML by IRLS to accommodate missing
covariate data and also kernel machine testing under complete case analysis to the motivating
epigenetic study of birth weight.
Infant birth weight is an important variable related a child’s subsequent development and
health. Consequently, it is of great interest to understand the factors influencing a child’s
birth weight, including genomic factors. The MoBa epigenetic study of birth weight aimed to
identify genes with methylation levels associated with differences in birth weight in infants.
To this end, cord blood from over 1100 Norwegian infants in the MoBa cohort was obtained.
The cohort has been described elsewhere. Following quality control, birth weight, covariates,
and CpG methylation information was available on 1069 individuals. CpGs within 20,631
genes were available for analysis. The objective of the analysis is to examine each gene, one-
71
5% missing
10
00
n 
In
de
pe
nd
en
t
0
20
60
10
0
15% missing
0
20
60
10
0
30% missing
0
20
60
10
0
60% missing
0
20
60
10
0
cc
oracle
irls
10
00
n 
Co
m
p 
Sy
m
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
10
00
n 
Au
to
re
g
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
10
00
n 
Bl
oc
kC
om
p 
Sy
m
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
10
00
n 
Bl
oc
kA
u
to
re
g
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
0
20
60
10
0
Figure 5.2: Scaled power estimates for kernel machine testing with complete case (cc)
treatment of missing data, with oracle knowledge of the missing covariate values, and with ML
by IRLS based analysis. Estimates are based on 10,000 simulated null model data sets under
different signifiance levels, percentage missingness, and correlation structures. The effect size
depended on the correlation structure to avoid saturation. Sample size is fixed at n = 1000.
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at-a-time, and test for the cumulative effect of the CpGs within the gene on birth weight
while adjusting for possible confounders.
Twelve different covariates related to birth weight were included in the analysis as possible
confounders. Five of the twelve were partially missing in some individuals, but four of these
five had 6 or fewer missing observations and so subjects missing in any of these four variables
were removed from analysis, resulting in 9 total observations removed. The fifth covariate,
vitamin D, had 123 missing values (11.6%) among the remaining 1060 observations which
resulted from failure to collect this information due to expense. Our simulations show power
loss when using complete case analysis coinciding with such a high percent of missingness.
Thus, we apply our maximum likelihood by IRLS methodology to this partially missing
covartiate. Vitamin D is a continuous covariate, thus we discretize the distribution, with 15
evenly spaced breaks. We standardized each of the covariates as well as the birth weight
outcome prior to analysis.
We first estimated the covariate effects, comparing complete case to ML without consideration
for the epigenetic data (i.e. under the null). Estimates of covariate effects were similar overall
for the two methods (Table 5.2). Gestastional age showed the largest difference since it had
the largest effect on the outcome.
We then conducted our primary analysis by applying kernel machine testing with ML by
IRLS to accommodate the missing vitamin D levels to each of the 20,631 groups of CpGs,
defined based on being in the same gene. Overall, following Bonferroni correction, 12 genes
were associated with birth weight. In contrast, if we were to apply complete case analysis,
reducing the sample size, then only three genes would have been found to be associated
with birth weight. The genes are show in Table 5.3. All genes discovered by complete case
analysis were also included in the list found by ML by IRLS reinforcing our simulation results
indicating that complete case analysis often leads to reduced power.
5.4 Discussion
Our results have showed that using maximum likelihood by iteratively reweighted least
squares is an attractive approach for multi-CpG association testing in the presence of partially
73
CC ML
Intercept -0.01 0.00
Infant Sex -0.14 -0.14
Cotinine -0.05 -0.06
Gest. Age 2.19 2.46
Gest. Age2 -1.69 -1.96
Parity = 1 0.19 0.19
Parity = 2 0.18 0.18
Parity ≥ 3 0.11 0.11
Maternal Age -0.11 -0.09
log1 0 Folate 0.08 0.08
Asthma 0.03 0.03
Preeclampsia -0.06 -0.07
Vitamin D 0.01 0.01
Table 5.2: Estimates of covariate effects on birth weight. The two procedures used are
complete case and maximum likelihood by iteratively reweighted least squares
Raw p Corrected p
CC IRLS CC IRLS
COBRA1 7.48E-05 2.20E-06 1.000 0.045
ENDOD1 7.37E-05 1.85E-06 1.000 0.038
FADS2 1.32E-05 4.24E-07 0.272 0.009
GRK6 1.54E-04 1.35E-06 1.000 0.028
GUCY1B2 1.13E-06 4.07E-07 0.023 0.008
KLF9 1.05E-06 2.08E-06 0.022 0.043
MBOAT4 9.19E-08 1.06E-08 0.002 <0.001
MNDA 1.43E-04 1.55E-06 1.000 0.032
SDPR 2.53E-06 2.76E-07 0.052 0.006
STAR 3.88E-06 7.50E-08 0.080 0.002
TRIM8 6.14E-05 1.37E-07 1.000 0.003
ZNF498 3.35E-05 5.96E-08 0.690 0.001
Table 5.3: Raw and Bonferroni Corrected p-values for the top results from the real data
analysis. Kernel machine testing with maximum likelihood via IRLS is denoted by IRLS.
Complete case analysis with kernel machine testing is denoted by CC.
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observed covariates. When compared to a hypothetical oracle procedure where the covariates
are not missing, power is only modestly decreased while type I error is conserved. On the
contrary, our results confirm previous studies showing that complete case can lead to biased
results and loss of power. Under certain correlation structures, complete case analysis can also
lead to substantially inflated type I error, though this was not observed within our analysis
of the MoBa epigenetic study of birth weight.
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Chapter 6
Evaluation of Statistical Methods for Prioritization and Selection of Individual
Rare Variants in Sequence Association Studies
6.1 Introduction
Despite the success of array based genome wide association studies (GWAS) of common
variants in identifying genetic variants associated with a range of traits and diseases, such as
Crohn’s diseaseWTCCC (2007), type I and type II diabetesWTCCC (2007), lung cancerLandi
et al. (2009); Li et al. (2010b), as well as many other traits (Hindorff et al., 2009), discovered
variants explain only a modest proportion of heritability (Eichler et al., 2010). A portion
of the missing heritability may be explained by rare genetic variants, that is variants with
low minor allele frequencies (MAF) which were difficult to study in the past. However,
recent advances in high-throughput sequencing technologySchuster (2008) have now enabled
large scale studies examining uncommon gene variants through sequencing association studies
which promise to identify rare genetic variants that further explain the heritability of complex
traits.
Achieving the promises of sequencing studies has proven challenging. In particular, it
is believed that analysis of these studies has been hindered by the low power of existing
analysis methods for GWAS when applied to study rare variants. Consequently, a range of
statistical methods have been developed for association testing in sequencing studiesLi and
Leal (2008, 2009); Madsen and Browning (2009); Price et al. (2010); Neale et al. (2011); Yi
and Zhi (2011); Wu et al. (2011). While there are important differences among the methods,
they generally share the common strategy of focusing on region based testing which aims to
assess the cumulative effect of multiple rare variants in a region on the trait value. “Region”
generally refers to a group of variants within a particular region of the genome (e.g. a
gene), but the definition can be expanded to encompass any group of variants of interest.
Aggregating information across multiple variants improves the power to identify regions that
are associated with particular traits. However, because the tests focus on examining the
joint effect of multiple uncommon variants, current methods cannot be used to conduct fine
mapping to identify individual causal variants.
While detecting trait associated regions is important, subsequent evaluation of the contributions
of individual causal variants within a gene region is crucial to achieving a comprehensive
understanding of how genetic variation affects disease etiology and complex trait architecture.
Pinpointing, or even prioritizing, individual variants would aid researchers interested in
conducting in-depth functional analyses to interpret association results biologically. This is
necessary to obtain clues as to the biological mechanisms underlying the relationship between
the genetic factors and the observed trait phenotypes and better identify possible diagnostic
and therapeutic options.
Although there has only been limited development of statistical methods for prioritizing
individual variants, many methods commonly used for common variants can also be applied
within the context of rare variants. Currently, the most common statistical tool used in
the identification of individual common variants is marginal regression analysis in which the
association between the trait value and each variant is examined, one-by-one. The method is
ubiquitous in GWAS and other high dimensional data types with individual variants surviving
some corrections for multiple comparisons considered to be of interest. An advantage of the
approach is that method includes ability to control type I error when used in conjuction with
multiple comparison correction. However, marginal analysis does not allow for the assessment
of the individual variants while in the pressence of other variants. Furthermore, the power
of standard tests for individual variants is tied to the MAF such that these methods may be
underpowered for testing individual rare variants, though there has been some recent evidence
that this power loss is over-stated.
As an alternative to marginal analysis, one may also consider methods that are built on
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multivariable regression models such as sparse penalized regression approaches. In particular,
variable selection procedures such as the Lasso (Tibshirani, 1996) operate under the multivariable
regression framework but have the ability to performing simultaneous estimation and variable
selection through inclusion of a penalty in the regression loss function. Sparse penalized
regression methods have been widely applied within the context of analyzing common genetic
variants for the purposes of fine mapping (Wu et al., 2009; Hoggart et al., 2008; He and Lin,
2010) and have also been proposed for analyzing rare genetic variants Zhou et al. (2010).
Unfortunately, the main drawback of Lasso and its derivatives (Fan and Li, 2001; Zou, 2006)
is that type I error control has not yet been established and some of these methods may
over-select such that non-trait related loci are also included within the final models.
Due to the irregularity of the limiting distribution, standard methods for inference may
not be appropriate within the context of sparse regression models. However, split sample
resampling based methods such as stability selection (Meinshausen and Bu¨hlmann, 2010)
and a number of other related approaches (Valdar et al., 2012) have been proposed to enable
error control. These methods have been applied within the context of analyzing common
genetic variants (Alexander and Lange, 2011; Eleftherohorinou et al., 2011) and may also be
useful for rare variants.
Although the properties of these procedures have been well studied, they have not been
evaluated in the context of sequencing data and rare variant selection. In this paper we
compare several of these methods in terms of their ability to correctly identify specific variants
within a region that are associated with the disease status or other outcome while minimizing
false positives. We also consider a simple approach which is based on forward selection in a
multvariable regression model in which we sequentially add variants to the model and generate
p-values conditional upon covariates and previously selected variants. Within these methods,
we can also consider weighting by MAF, and the use of prior biological information on the
ability to detect predictive genetic variants. Polyphen-2 (Adzhubei et al., 2010) and SIFT
(Ng and Henikoff, 2003), for example, are becoming increasingly useful biological predictive
tools. We compare the performance of each of these methods under three different criteria.
First, we compare the methods with respect to selection of truly trait associated variants
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(true positives) and incorrect selection of non-associated variants (false positives). Second we
compare the ability to detect true postives indexed by minor allele frequency (MAF). Some
methods may have better ability to identify associated variants that are relatively common
or that are relatively rare. Finally, we compare ability of each method to rank order the
individual variants into a relative list of importance.
6.2 Methods
In this paper, we focus on sequencing studies considering continuous traits. We assume
that the study population consists of n unrelated subjects and we further assume that we are
interested in identifying the causal variants within a single region.
For the ith subject (i = 1, · · · , n), let yi denote the value of the quantitative trait. Xi =
(xi1, xi2, · · · , xiq)T denotes the covariates which can be either continuous or discrete and
Zi = (zi1, zi2, · · · , zip)T denotes the genotype values of the p variants within the sequenced
regions. We will assume an additive genetic model such that zij is the number of the minor
alleles of the jth SNP, but we emphasize that our approach can also easily accommodate a
dominant or recessive genetic model by simply changing the coding for zij .
Since we are focusing on quantitative traits, we employ a linear model defined by
yi = β0 + β
TXi + γ
TZi + i (6.1)
where β0 is the intercept, β is the coefficient vector for the covariates, and γ = (γ1, γ2, · · · , γp)T
is the coefficient vector for the p variants. The error term i is assumed to have mean 0 and
variance σ2.
Since not all of the variants within the region are anticipated to be related to the outcome,
the objective is to identify the variants Zij with corresponding γj 6= 0 such that the variant
influences the outcome. In this section, we examine several different approaches that can be
used to do this.
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6.2.1 Marginal Analysis
The most commonly used method in genetic association studies is the marginal analysis
such as by ordinary least squares for quantitative traits. Under this approach, each variant
is tested separately for association with an outcome such as a disease while accomodating
covariates such as environment or demographics. In particular, the effect of the jth variant is
evaluated assuming the model
yi = β0 + β
′Xi + γjzij + εi.
A 1-df test can be used to test whether γj differs from zero. Then to achieve variable selection,
the p-value for the association of the individual variant can be compared to a prespecified
level. If it is below the level, then it is selected. If one wishes to control the type I error,
then the threshold can be based on a pre-specified α-level to control family wise error rate
(FWER) or adjusted to control the Benjamini-Hochberg false discovery rate (FDR) or some
other criterion.
A common belief is that rare variants are more likely to influence trait values. Similarly,
bioinformatics tools are now able to provide some prediction as to whether individual variants
influence trait values. Weighting can be used to incorporate this prior knowledge and belief
within this setting. One possible approach is to use the weighted FDR approach of Genovese
et al. (2006). For example, if one wishes to incorporate MAF information into the selection
process, using FDR we can multiple the p-value for each variant by the MAF of the corresponding
variant which has been normalized by the total MAF to generate a weighted p-value
pw,k = pk ∗ wk = pk ∗ (
p∑
k=1
MAFk)
−1MAFk.
Since the arithmetic mean of the weights is equal 1, then FDR is conserved.
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6.2.2 Lasso Based Methods
Another popular tool in variable selection in genetic association studies is the Lasso.
Briefly, the Lasso operates under Model 6.1 and estimates the regression coefficients for the
covariates β and the variants γ using the L1 penalized loss function
β̂, γ̂ = argmin
β,γ
||y − β0 −Xβ − Zγ||22 + λ
p∑
j=1
|γj |.
The inclusion of the L1 penalty allows for sparse estimation of the γs, i.e. for some of the
γs to be estimated as exactly zero, when λ is large. λ is typically selected by grid search
combined with cross validation or optimization of some criterion such as generalized cross
validation (GCV) or BIC. For the purposes of this article, we use the AIC criterion (Akaike,
1974) for selection of λ.
Since all of the variants are considered simultaneously, it allows for some accommodating
of correlation between variants and evaluation of the variants in the pressence of others. In
the Lasso, there are no p-values to report, but rather simply the estimate of the variants’
effect.
Within the context of the Lasso, it is also possible to use weighting to incorporate prior
biological knowledge as with marginal analysis. In particular, we can use variant specific
weights to adjust the penalty for each individual variant such that we estimate β and γ as
β̂, γ̂ = argmin
β,γ
||y − β0 −Xβ − Zγ||22 + λ
p∑
j=1
wj |γj |
where wj is a prior weight that is related to the prior belief of the importance of the j
th
variant. Larger values of wj effectively increase the penalty for the j
th variant such that it is
more likely to be shrunken to zero. Under the adaptive Lasso (Zou, 2006) sets wj to |γˆj |−1
where γ̂j is some prior estimate for γj usually unpenalized least squares estimate, which
allows for consistent variable selection under some conditions. Instead of using an initial
estimate, we can also incorporate prior knowledge based on which variants are more likely to
be causal. Thus, we can use weights that make it more likely for rare variants to be selected.
81
Specifically, for the jth variant, we set the weight to be equal to the MAF for the jth variant:
since we believe variants with lower MAF are more likely to be important, this reduces the
corresponding penalty for the variant making it more likely to be selected.
6.2.3 Stability Selection
In part because the Lasso does not control type I error and is believed to often over-
select (leading to many false positives), Meinshausen and Bu¨hlmann (2010) have proposed
the stability selection procedure which is based on resampling the data and applying Lasso to
allow for control of the expected number of false positives (the Per-Family Error Rate, PFER).
Variants that are frequent selected across resamples are more likely to be true associated with
the trait.
Operationally, stability selection proceeds by:
1. Randomly sample n/2 subjects from the total of n subjects in the study.
2. Apply the Lasso (or the weighted Lasso) using only the sampled n/2 subjects to select
variants related to the outcome, but instead of optimizing a particular criterion, we
select q, a prespecified number, of variants. Let Sn/2 denote the set of selected variants
in the particular subsample.
3. Repeat the previous two steps B times for some large number B.
4. For each variant k, compute the selection probability as the proportion of times that
the variant is selected across subsamples
pˆk,n/2,B =
1
B
B∑
b=1
I(k ∈ Sˆn/2,b)
5. Variants whose selection probability is greater than a prespecified threshold (τ) are
reported as selected.
By choosing different values of τ , stability selection can control the PFER by making two
generally reasonable assumptions: 1) exchangeability, that is, all noncausal variants have
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equal chance of selection; and 2) the using Lasso procedure is no worse than guessing. The
PFER increases as the number of selected variables per subsample increases, and decreases
with increasing total variables and increasing the threshold τ at which to accept a variable.
The specific bound is given as
PFER ≤ 1
2τ − 1
q2
p
.
We note that this is an upper bound and that in practice, the observed PFER is usually
substantially lower if the data and procedure are adequate due to the assumptions used in
developing the bound.
6.2.4 Forward Selection
The final method we examine is based on simple forward selection. Although penalized
regression methods have become quite popular in the statistical literature, forward selection
is stll commonly used within many applied scenarios. Forward selection is applied by first
testing individual variants for association with the outcome in the presence of all covariates.
The single variant most highly associated with the outcome is then selected. We then include
the selected variant as a covariate and then test each of the remaining variants for association
with the outcome. The single variant most highly associated with the outcome, conditional
on the covariates and the first selected variant, is again selected. This is repeated until all
variants that are at all significantly associated with the outcome is added to the model.
Operationally, for testing the effect of additional variants while conditioning on previously
selected variants and covariates, we use the score test implemented within SKAT. Since we
are only testing a single variant, this score test is essentially equivalent to a standard 1-df
score test within a multivariable regression model.
6.3 Simulations
We conducted a series of simulation studies to examine the relative performance of the
considered methods for prioritizing and selecting individual variants that may be responsible
for driving region level associations.
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To simulate real sequencing data, we first generated a population of 10,000 haplotypes on
a region of approximately 10 kb in length, containing 200 variants, using a coalescent model
(Schaffner et al., 2005) calibrated to reflect a population of European ancestry. Using this
population of haplotypes, we randomly selected 2n haplotypes and paired them to generate n
diploid individuals. The vector of additively coded genotypes for the ith simulated individual
are given as Zi. We then simulated an outcomes for each of the i = 1, . . . , n individuals using
the model
yi = 0.5xi1 + 0.5xi2 + γ
′Zci + εi
where xi1 ∼ N(0, 1), xi2 ∼ ber(0.5) and εi. Zci are the genotypes of the causal variants which
were randomly selected as 20% of the variants with true MAF less than 1% in the simulated
population. The coefficients for the causal variants are γ with γj , the coefficient for the j
th
causal variant, set equal to rj0.4|log10MAFj | where rj is -1 and 1 with probabilities 0.2 and
0.8, respectively.
Since we are sometimes provided with prior biological knowledge concerning whether
individual variants are actually causal, we also considerd simulation of scores reflecting prior
knowledge. To mimic scenarios in which we have informative prior knowledge, we simulated
scores from a Beta(2.5, 0.25) distribution for causal variants and we simulated scores from
a Beta(0.25, 2.5) distribution for non-causal variants. These scores are meant to behave
similarly to scores from Polyphen-2 or SIFT. We also considered some scenarios in which the
prior knowledge is of poor quality and in these anti-informative settings, the distributions for
causal and non-causal variants were reversed.
We considered several different scenarios based on different sample sizes and whether or
not prior knowledge was useful. For each scenario, we simulated 1000 data sets. We applied
each of the considered methods to each of the data sets to try to identify the individual causal
variants. A number of different metrics for assessing the methods were considered.
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6.3.1 Evaluative Metrics
We compare the methods in three ways. First, we examine number of true positives and
false positives in relation to the total number of causal variants which which observed to
have at least one minor allele in the data set. It is desirable to capture a large proportion
of observed causal rare variants, but also to have a low number of false positives. Second
we examine the number of true positives broken down by the minor allele frequency of the
population from which the samples are drawn. This will give a picture of relative advatage
by method with respect to the rarity of the variant. It may be helpful for the investigator to
know the relative advantages of the methods prior to analysis. For example, the invistagor
may be interested in more common variants because of higher population penetration. Or,
contrarily, the investigator may be interested in rarer variants because they may be more
potent.
Finally, we compare the methods in their ability to prioritize the variants in order of
importance. Suppose further investigation requires a list of 5, 10 or 20 candidate variants.
Analysis which automatically prioritizes will be ready to generate an imformative list. For
our study, we use p-values to rank marginal anlaysis and SKAT forward ranks. We rank by
magnitude of effect estimate for the Lasso. Stability selection ranks by the estimated selection
probability. The formula we use produces a ”rankscore” which ranges from 0 (none of the top
20 ranked variants are causal) to 1 (all top 20 ranked variants are causal). The formula gives
higher priority to top ranked variants by weighting the top ranked variant 20, second 19, until
the lowest 1, with the final score scaled to produce range 0 to 1. Rankscore is calculated as:
c
l∑
r=1
(l + 1− r)I(zr ∈ S)
where zr represents the r ranked variant. l is the length of the list and S is the group of true
associated variants. c is the scaling factor (
∑l
r=1 r)
−1 which ensures a score between 0 and 1.
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6.3.2 Results
Table 6.1 displays results with under the scenario in which set let n = 1000 and no prior
knowledge was available beyond allele frequency. From the table, we see that Lasso methods
captured a greater proportion of the causal variants. Here there were an average of 15.5
observed causal rare variants across simulations, representing the maximum number of true
positives that any approach can find. The Lasso methods captured on average close to 11 of
these, while any other methods failed to catch more than 5. However the drawback is that
Lasso methods have no way to control type I error and tend to vastly over-select. This was
clearly seen in the high number of false positives selected through AIC.
Examination of true postives by MAF shows that gains in power were more prevalent in
the lower range of MAF for the Lasso method, especially the very rare variants with MAF less
than 0.1% where Lasso based methods capture 8 to 9 compared to 2 to 3 in the other methods.
Finally, Lasso based methods, and also SKAT forward selection, showed the greatest ability
to correctly arrange variants by level of importance, since the rank score was high.
Now, among the Lasso methods, adaptive and naive Lasso show better ability than
weighted Lasso. This may have been partially due to the fact that the LASSO requires
standardization of the design, and thus since standard deviation is clearly already related to
MAF, is automatically adjusted for MAF. Further weighting is unecessary or perhaps harmful
according to these results.
Among methods which had lower false positive rates, forward selection using SKAT had
the most desireable outcomes. In fact SKAT forward selection dominated both marginal
analysis and stability selection in that it had both more TP and fewer FP. SKAT forward
had rank score on par with Lasso based methods and higher than the other error-controlled
methods.
Weighting as a general strategy seemed to range from uncertain gain to unhelpful. It is
not clearly shown in any method that weighting by MAF increased TP while lowering FP.
Examining the effect of sample size on abilty of the methods to detect causal variants
shown in figure 6.1, we saw patterns seen for the default 1000 sample size persist in the other
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TP by MAF
TP FP 1% to 0.5% 0.5% to 0.1% ≤ 0.1% rank.score
Marginal 2.3 0.7 0.5 1.0 0.9 0.42
Marginal-w 2.8 0.8 0.4 0.9 1.6 0.53
Lasso 10.9 15.2 0.6 2.3 8.1 0.62
Lasso-w 11.2 27.8 0.3 1.3 9.6 0.52
Adaptive Lasso 11.6 16.0 0.5 2.2 8.8 0.61
Stability Selection τ =0.6 4.9 3.5 0.5 2.0 2.4 0.49
Stability Selection τ =0.7 3.1 1.0 0.5 1.6 1.0 0.49
SKAT forward 3.2 0.3 0.5 1.2 1.5 0.63
SKAT forward-w 4.5 0.8 0.5 1.2 2.8 0.63
Mean observed 15.5 68.2 0.6 2.6 12.3
Table 6.1: Comparison of methods in ability to correctly identify causal variants for default
simulation setting. Measures of comparison include true positives, false positives, and true
postitives indexed by minor allele frequency. Additionally presented is a rankscore, which
measures ability to informatively order variants by level of importace, with 1 meaning all 20
top ranked variants are causal, and 0 meaning none are causal.
sample sizes as well. While all methods improve detection with increased sample size, stabilty
selection showed much more variability due to sample size, with poor results in the n = 500
setting.
Finally, we examined the effect of prior information. All methods except stability selection
gained from informative prior information. All methods clearly performed poorly under
anti-informative prior information. This indicates that inclusion of prior knowledge can
significantly improve analyses, but inclusion of unreliable knowledge or knowledge that goes
against the truth can result in decreased ability to identify causal variants.
6.4 Data Analysis
6.4.1 Overview
We applied the four methods to a real data set, in which we wished to find genetic variants
associated with a quantitative trait related to lung function across 1898 individuals. The trait
was continuous and the data set contained 8 additional covariates. Within the region, there
were 86 genetic variants, of which 17 had MAF over 1%, 2 between 0.5% and 1%, 16 between
0.1% and 0.5%, and 51 less than 0.1%. We applied the methods as before and reported the
87
n = 500
TP/FP: mean observed 11 causal/ 59 total
TP
/F
P
0
2
4
6
8
10
12
LM
LM
−w
LA
SS
O
W
−L
AS
SO
AD
−L
AS
SO
SS
ta
u0
.6
SS
ta
u0
.7
SK
AT
 fw
d
SK
AT
 fw
d−
w
TP
FP
TP by Minor Allele Frequency
Tr
u
e
 P
o
si
tiv
e
s 
by
 M
AF
0
1
2
3
4
5
LM
LM
−w
LA
SS
O
W
−L
AS
SO
AD
−L
AS
SO
SS
ta
u0
.6
SS
ta
u0
.7
SK
AT
 fw
d
SK
AT
 fw
d−
w
Mean observed
causals
>1% : 0
.5% to 1% : 0.6
.1% to .5% : 2.4
<=.1% : 7.7
TP Score weighted by rank (0 to 1)
R
an
ks
co
re
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
LM
LM
−w
LA
SS
O
W
−L
AS
SO
AD
−L
AS
SO
SS
ta
u0
.6
SS
ta
u0
.7
SK
AT
 fw
d
SK
AT
 fw
d−
w
n = 1000
TP/FP: mean observed 15 causal/ 84 total
TP
/F
P
0
5
10
15
20
25
LM
LM
−w
LA
SS
O
W
−L
AS
SO
AD
−L
AS
SO
SS
ta
u0
.6
SS
ta
u0
.7
SK
AT
 fw
d
SK
AT
 fw
d−
w
TP
FP
TP by Minor Allele Frequency
Tr
u
e
 P
o
si
tiv
e
s 
by
 M
AF
0
2
4
6
8
LM
LM
−w
LA
SS
O
W
−L
AS
SO
AD
−L
AS
SO
SS
ta
u0
.6
SS
ta
u0
.7
SK
AT
 fw
d
SK
AT
 fw
d−
w
Mean observed
causals
>1% : 0
.5% to 1% : 0.6
.1% to .5% : 2.6
<=.1% : 12.3
TP Score weighted by rank (0 to 1)
R
an
ks
co
re
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
LM
LM
−w
LA
SS
O
W
−L
AS
SO
AD
−L
AS
SO
SS
ta
u0
.6
SS
ta
u0
.7
SK
AT
 fw
d
SK
AT
 fw
d−
w
n = 2000
TP/FP: mean observed 21 causal/ 112 total
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Figure 6.1: Simulation results for varied sample size. Left column compares methods by true
postives and false postives, with total observed causal variants and total variants noted for
comparison. Middle column compares methods by true postives with respect to minor allele
frequency, with total observed variant by MAF noted for comparison. Right column compares
methods by their ability to order variants by rank of importance, with 0 worst and 1 perfect.
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Figure 6.2: Simulation results for varied prior information. Left column compares methods by
true postives and false postives, with total observed causal variants and total variants noted
for comparison. Middle column compares methods by true postives with respect to minor
allele frequency, with total observed variant by MAF noted for comparison. Right column
compares methods by their ability to order variants by rank of importance, with 0 worst and
1 perfect.
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Total > 1% 1% to 0.5% 0.5% to 0.1% ≤ 0.1%
Marginal 1 0 0 1 0
Marginal-w 2 0 0 1 1
LASSO 3 0 0 1 2
LASSO-w 16 0 0 1 15
Adaptive LASSO 5 0 0 1 4
Stability Selection τ =0.6 2 1 0 0 1
Stability Selection τ =0.7 1 0 0 0 1
SKAT forward 1 0 0 1 0
SKAT forward-w 2 0 0 1 1
Mean observed 86 17 2 16 51
Table 6.2: Real data application: Comparison of methods in number of variants identified as
being associated with homeostatic model assessment levels. Measures of comparison include
total selected variants, and selected variants indexed by minor allele frequency.
number of variants selected.
6.4.2 Results
The Lasso based methods selected several variants (Table 6.2). Marginal regression found
1 variant without weighting, and 2 with weighting. The naive Lasso found 3 association,
weighted Lasso found 16, while adaptive Lasso found 5. Stability selection found 2 and 1
at τ equal to 0.6 and 0.7 respectively. SKAT forward selection found 1 variant without
weighting, and 2 with weighting. Overall, results are similar to what we anticipated based on
the simulation results.
6.5 Discussion
Lasso methods provide the power to detect the greatest number of associated variants, but
lack type I error control and consequently result in large numbers of false positives. Neither
adaptive Lasso nor weighting by minor allele frequency seem to increases power or reduce
false positives.
Among methods which provide adequate error control SKAT forward selection provides
the greater power than marginal analysis. These methods are useful when the desired result
is a ”clean” list of variants with prespecified number of false postivies. When relative order
of importance is of greatest concern Lasso and SKAT forward selection provide the greatest
90
precision.
Stability selection, which applies observation resampling to Lasso, provides crude error
control, but performs poorly under moderate sample size. It is dominated by SKAT forward
selection in both true positives and false positives and cannot be recommended.
All methods benefit greatly from the use of informative prior information, such as that
provided by Polyphen-2 or SIFT.
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APPENDIX: SUPPLEMENTARY MATERIAL FOR CHAPTER 4
A1 Derivation of IRLS Newton Raphson: Partially Observed Discrete Covariate
Here we derive the Newton Raphson algorithm to solve IRLS weighted maximum likelihood
for β, σ2, α (It is not necessary to estimate ω)
wl(y, x2|x1, β, σ2, α) = wl(y|x1, x2, β, σ2) + wl(x2|x1, α)
= −
∑
wi
2
log σ2 −
∑
wi
2
log 2pi −
∑
wi(yi −Xiβ)2
2σ2
+
∑
wix2,iXiα−
∑
wi log(1 + e
Xiα) =
dl
dβ
=
∑
XTi wi(yi −Xiβ)
σ2
dl
dσ2
= −
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2σ2
+
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wi(yi −Xiβ)2
2(σ2)2
d2l
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=
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(σ2)2
d2l
d(σ2)2
=
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2(σ2)2
−
∑
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(σ2)3
Thus:  β(t+1)
σ2(t+1)
 =
 β(t)
σ2(t)
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∑
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d2l
dα2
= −
∑
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Thus:
α(t+1) = α(t) +
[∑
XTi wiXiµi(1− µi)
]−1∑
XTi wi(x2,i − µi)
A2 Derivation of IRLS Newton Raphson: Partially Observed Continuous Covariate
Here we derive the Newton Raphson algorithm to solve IRLS weighted maximum likelihood
for β, σ2y , α, σ
2
x (It is not necessary to estimate ω). We assume that X1 is fully observed and
X2 partially observed.
wl(y, x2|x1, β, σ2y , α, σ2x) = wl(y|x1, x2, β, σ2y) + wl(x2|x1, α, σ2x)
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